NewzIntel.com

Category: Internet of Things

  • MIL-OSI: Form 8.3 – [ADVANCED MEDICAL SOLUTIONS GROUP PLC – 09 04 2025] – (CGWL)

    Source: GlobeNewswire (MIL-OSI)

    FORM 8.3

    PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY
    A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE
    Rule 8.3 of the Takeover Code (the “Code”)

    1.        KEY INFORMATION

    (a)   Full name of discloser: CANACCORD GENUITY WEALTH LIMITED (for Discretionary clients)
    (b)   Owner or controller of interests and short positions disclosed, if different from 1(a):
            The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.    		 N/A
    (c)   Name of offeror/offeree in relation to whose relevant securities this form relates:
            Use a separate form for each offeror/offeree    		 ADVANCED MEDICAL SOLUTIONS GROUP PLC
    (d)   If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree: N/A
    (e)   Date position held/dealing undertaken:
            For an opening position disclosure, state the latest practicable date prior to the disclosure    		 09 APRIL 2025
    (f)   In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?
            If it is a cash offer or possible cash offer, state “N/A”    		 N/A

    2.        POSITIONS OF THE PERSON MAKING THE DISCLOSURE

    If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

    (a)      Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

    Class of relevant security: 5p ORDINARY
      Interests Short positions
    Number % Number %
    (1)   Relevant securities owned and/or controlled: 11,862,906 5.4410    
    (2)   Cash-settled derivatives:        
    (3)   Stock-settled derivatives (including options) and agreements to purchase/sell:        
    TOTAL: 11,862,906 5.4410    

    All interests and all short positions should be disclosed.

    Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

    (b)      Rights to subscribe for new securities (including directors’ and other employee options)

    Class of relevant security in relation to which subscription right exists:  
    Details, including nature of the rights concerned and relevant percentages:  

    3.        DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

    Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

    The currency of all prices and other monetary amounts should be stated.

    (a)        Purchases and sales

    Class of relevant security Purchase/sale Number of securities Price per unit
    5p ORDINARY SALE 3,240 184.6p
    5p ORDINARY SALE 21,590 198.4p
    5p ORDINARY PURCHASE 3,240 185.5453p

    (b)        Cash-settled derivative transactions

    Class of relevant security Product description
    e.g. CFD    		 Nature of dealing
    e.g. opening/closing a long/short position, increasing/reducing a long/short position    		 Number of reference securities Price per unit
    NONE        

    (c)        Stock-settled derivative transactions (including options)

    (i)        Writing, selling, purchasing or varying

    Class of relevant security Product description e.g. call option Writing, purchasing, selling, varying etc. Number of securities to which option relates Exercise price per unit Type
    e.g. American, European etc.    		 Expiry date Option money paid/ received per unit
    NONE              

    (ii)        Exercise

    Class of relevant security Product description
    e.g. call option    		 Exercising/ exercised against Number of securities Exercise price per unit

    (d)        Other dealings (including subscribing for new securities)

    Class of relevant security Nature of dealing
    e.g. subscription, conversion    		 Details Price per unit (if applicable)
    NONE      

    4.        OTHER INFORMATION

    (a)        Indemnity and other dealing arrangements

    Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:
    Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state “none”

    NONE

    (b)        Agreements, arrangements or understandings relating to options or derivatives

    Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to:
    (i)   the voting rights of any relevant securities under any option; or
    (ii)   the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:
    If there are no such agreements, arrangements or understandings, state “none”

    NONE

    (c)        Attachments

    Is a Supplemental Form 8 (Open Positions) attached? NO
    Date of disclosure: 10 APRIL 2025
    Contact name: MARK ELLIOTT
    Telephone number: 01253 376539

    Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

    The Panel’s Market Surveillance Unit is available for consultation in relation to the Code’s disclosure requirements on +44 (0)20 7638 0129.

    The Code can be viewed on the Panel’s website at www.thetakeoverpanel.org.uk.

    The MIL Network –

  • MIL-OSI: Form 8.3 – [ADVANCED MEDICAL SOLUTIONS GROUP PLC – 09 04 2025] – (CGAML)

    Source: GlobeNewswire (MIL-OSI)

    FORM 8.3

    PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY
    A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE
    Rule 8.3 of the Takeover Code (the “Code”)

    1.        KEY INFORMATION

    (a)   Full name of discloser: CANACCORD GENUITY ASSET MANAGEMENT LIMITED (for Discretionary clients)
    (b)   Owner or controller of interests and short positions disclosed, if different from 1(a):
            The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.    		 N/A
    (c)   Name of offeror/offeree in relation to whose relevant securities this form relates:
            Use a separate form for each offeror/offeree    		 ADVANCED MEDICAL SOLUTIONS GROUP PLC
    (d)   If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree: N/A
    (e)   Date position held/dealing undertaken:
            For an opening position disclosure, state the latest practicable date prior to the disclosure    		 09 APRIL 2025
    (f)   In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?
            If it is a cash offer or possible cash offer, state “N/A”    		 N/A

    2.        POSITIONS OF THE PERSON MAKING THE DISCLOSURE

    If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

    (a)      Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

    Class of relevant security: 5p ORDINARY
      Interests Short positions
    Number % Number %
    (1)   Relevant securities owned and/or controlled: 4,775,000 2.1901    
    (2)   Cash-settled derivatives:        
    (3)   Stock-settled derivatives (including options) and agreements to purchase/sell:        
    TOTAL: 4,775,000 2.1901    

    All interests and all short positions should be disclosed.

    Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

    (b)      Rights to subscribe for new securities (including directors’ and other employee options)

    Class of relevant security in relation to which subscription right exists:  
    Details, including nature of the rights concerned and relevant percentages:  

    3.        DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

    Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

    The currency of all prices and other monetary amounts should be stated.

    (a)        Purchases and sales

    Class of relevant security Purchase/sale Number of securities Price per unit
    5p ORDINARY PURCHASE 85,000 200.5533p

    (b)        Cash-settled derivative transactions

    Class of relevant security Product description
    e.g. CFD    		 Nature of dealing
    e.g. opening/closing a long/short position, increasing/reducing a long/short position    		 Number of reference securities Price per unit
    NONE        

    (c)        Stock-settled derivative transactions (including options)

    (i)        Writing, selling, purchasing or varying

    Class of relevant security Product description e.g. call option Writing, purchasing, selling, varying etc. Number of securities to which option relates Exercise price per unit Type
    e.g. American, European etc.    		 Expiry date Option money paid/ received per unit
    NONE              

    (ii)        Exercise

    Class of relevant security Product description
    e.g. call option    		 Exercising/ exercised against Number of securities Exercise price per unit

    (d)        Other dealings (including subscribing for new securities)

    Class of relevant security Nature of dealing
    e.g. subscription, conversion    		 Details Price per unit (if applicable)
    NONE      

    4.        OTHER INFORMATION

    (a)        Indemnity and other dealing arrangements

    Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:
    Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state “none”

    NONE

    (b)        Agreements, arrangements or understandings relating to options or derivatives

    Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to:
    (i)   the voting rights of any relevant securities under any option; or
    (ii)   the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:
    If there are no such agreements, arrangements or understandings, state “none”

    NONE

    (c)        Attachments

    Is a Supplemental Form 8 (Open Positions) attached? NO
    Date of disclosure: 10 APRIL 2025
    Contact name: MARK ELLIOTT
    Telephone number: 01253 376539

    Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

    The Panel’s Market Surveillance Unit is available for consultation in relation to the Code’s disclosure requirements on +44 (0)20 7638 0129.

    The Code can be viewed on the Panel’s website at www.thetakeoverpanel.org.uk.

    The MIL Network –

  • MIL-OSI USA: REPS. LAUREN BOEBERT AND TOM TIFFANY’S GRAY WOLF BILL PASSES THROUGH HOUSE NATURAL RESOURCES COMMITTEE

    Source: United States House of Representatives – Representative Lauren Boebert (Colorado, 3)

    WASHINGTON D.C.– The Pet and Livestock Protection Act (PALPA) introduced by Congresswoman Lauren Boebert (CO-04) and Congressman Tom Tiffany (WI-07) passed through the House Natural Resources Committee today, a major milestone for this legislation’s path to President Trump’s desk. The House Natural Resources Committee voted 24-17 to advance the bill to the House floor.

    The bill delists the gray wolf from the Endangered Species List, prioritizes the safety and success of America’s agriculture community, removes the ability of progressive, activist judges to get in the way of science and allows states to set their own rules and regulations for managing their gray wolf population. 

    “I’m very excited to see PALPA take another step towards being signed into law, which will be a huge victory for our ranchers, farmers, and landowners in Colorado and across America,”said Congresswoman Boebert. “The science has been very clear on this topic for years: gray wolves are fully recovered and their comeback should be touted as a success story. Now it’s time we encourage states to set their own guidelines and allow ranchers, farmers, and landowners to protect their livelihoods. I look forward to voting for this bill on the House floor and ultimately getting it to President Trump for his signature.”

    “The damage to pets, livestock, and wildlife from an unmanaged wolf population can no longer be ignored. The gray wolf has exceeded federal and state recovery goals, with over 1,000 wolves now thriving in Wisconsin. It’s time to take the next step, delist them, and let the people closest to the gray wolf manage their population levels.” said Congressman Tiffany.

    “The Endangered Species Act was never meant to be a Hotel California where species check in but never leave. Congresswoman Boebert and Congressman Tiffany’s Pet and Livestock Protection Act will allow the recovered gray wolf to check out and return management to the states who know the species best. I thank Ms. Boebert and Mr. Tiffany for their work on this important issue,” said House Natural Resources Committee Chairman Bruce Westerman (AR-04).

    “The Colorado Wool Growers Association greatly appreciates Congresswoman Boebert and Congressman Tiffany’s leadership on the efforts to delist the gray wolf,” said Bonnie Eddy, Executive Director of the Colorado Wool Growers Association. “With over 2,000 wolves on the landscape in the western United States, the species has been biologically recovered for years.  Unfortunately, ESA species are often used to restrict land use and control habitat.  Delisting will give farmers, ranchers, and agencies much needed flexibility to manage depredating wolves that kill livestock and to manage the negative impacts to our big game herds.”

    “Hunter Nation salutes the House Natural Resources Committee for voting the ‘Pet and Livestock Protection Act’ out of committee, and thanks Congressman Tom Tiffany and Congresswoman Lauren Boebert for their unwavering support of hunters and our hunting lifestyle,” said Keith Mark, President/Founder of Hunter Nation. “The delisting of the gray wolf is a policy change we have been fighting for since our founding. The recovery of the gray wolf is an incredible conservation success story that should be celebrated. This legislation allows each state to manage the now recovered wolf population just as they manage all other wildlife within the state. The best part of this legislation is the provision that prevents judicial review of the legislative action which will preclude anti-hunting groups from using activist judges to interfere with sound, science-based conservation.”

    “Colorado’s Western Slope has the second largest deposit of natural gas in the world, and wolves on the landscape will put drilling and investing at a full stop–you can open up all the leases and it won’t make a difference if wolves aren’t delisted and dealt with. Energy producers need this bill to pass, or they’ll just pack up and leave the wolves and Colorado’s economy behind,” said Mike Clark, Chairman of the Colorado Conservation Alliance. 

    Congresswoman Boebert’s opening statement from today’s Committee hearing can be found HERE.

    Additional Reading:

    9News: Wolf from Great Lakes dies in Elbert County, Colorado

    USA Today: Colorado Gray Wolf killed after attacking 5 sheep in Wyoming

    The Gazette: Wolves from Canada Arrive in Colorado, Destination Unknown

    Colorado Sun: Ranchers hit Colorado with $580,000 in wolf depredation claims after gray wolf attacks on livestock

    Background:

    The Pet and Livestock Protection Act requires the Secretary of the Interior to reissue the 2020 Department of the Interior final rule that delisted gray wolves in the lower 48 United States. It also ensures this rule cannot be overturned through judicial review, preventing activist judges, like the California judge who vacated the rule in 2022, from relisting the gray wolf by judicial fiat.

    In 2020, the Department of the Interior and the U.S. Fish and Wildlife Service under President Trump delisted the gray wolf in the lower 48 United States through a process that included the best science and data available. At over 6,000 wolves at the time of delisting, the gray wolf has been the latest Endangered Species Act (ESA) success story with significant population recoveries in the Rocky Mountains and western Great Lakes regions.

    Despite clear evidence of recovery, a California judge overturned the rule in 2022, relisting the gray wolf under the ESA. In Colorado, foreign gray wolves have been imported in from Canada despite strong pushback from local stakeholders and confusion about how to fund wolf depredation claims.

    32 Members of Congress cosponsored the Pet and Livestock Protection Act, including: Reps. Nick Begich (AK-At-Large), Jack Bergman (MI-01), Andy Biggs (AZ-05), Cliff Bentz (OR-02), Jeff Crank (CO-05), Eli Crane (AZ-02), Troy Downing (MT-02), Tom Emmer (MN-06), Gabe Evans (CO-08), Scott Fitzgerald (WI-05), Brad Finstad (MN-01), Michelle Fischbach (MN-07), Russ Fulcher (ID-01), Paul Gosar (AZ-09), Glenn Grothman (WI-06), Harriet Hagemann (WY-At-Large), Andy Harris (MD-01), Jeff Hurd (CO-03), Richard Hudson (NC-09), Mike Kennedy (UT-03), Doug LaMalfa (CA-01), Max Miller (OH-07), John Moolenaar (MI-02), Dan Newhouse (WA-04), Troy Nehls (TX-22), Andy Ogles (TN-05), Scott Perry (PA-10), Bryan Steil (WI-01), Pete Stauber (MN-08), Derrick Van Orden (WI-03), and Tony Wied (WI-08).

    Stakeholders that support the Pet and Livestock Protection Act include: American Farm Bureau Federation, National Cattlemen’s Beef Association (NCBA), Public Lands Council (PLC), National Rifle Association (NRA), Safari Club International (SCI), Hunter Nation, International Order of T. Roosevelt (IOTR), Congressional Sportsmen’s Foundation, Mule Deer Foundation, Blacktail Deer Foundation, Colorado Farm Bureau, Colorado Conservation Alliance, Colorado Wool Growers, New Mexico Cattle Growers, Mesa County, CO, Minnesota Lamb & Wool Producers Association, Coalition of Arizona/New Mexico Counties, Rocky Mountain Elk Foundation, Wisconsin Farm Bureau Federation, Wisconsin Cattlemen’s Association, Nebraska Cattlemen, and Wisconsin Bear Hunters Association.

    MIL OSI USA News –

  • MIL-OSI USA: Tiffany’s Wolf Delisting Bill Clears House Natural Resources Committee

    Source: United States House of Representatives – Representative Tom Tiffany (WI-07)

    WASHINGTON, DC – Today, Congressman Tom Tiffany (WI-07) and Congresswoman Lauren Boebert’s (CO-04) legislation to delist the gray wolf from the Endangered Species List and ensure that action is not subject to judicial review passed out of the House Natural Resources Committee. The Pet and Livestock Protection Act will restore authority back to state lawmakers and state wildlife officials to control the gray wolf population. H.R. 845 will now head to the full House of Representatives for a vote.   

    “The damage to pets, livestock, and wildlife from an unmanaged wolf population can no longer be ignored. The gray wolf has exceeded federal and state recovery goals, with over 1,000 wolves now thriving in Wisconsin. It’s time to take the next step, delist them, and let the people closest to the gray wolf manage their population levels,” said Congressman Tiffany.  

    “I’m very excited to see PALPA take another step towards being signed into law, which will be a huge victory for our ranchers, farmers, and landowners in Colorado and across America,” said Congresswoman Boebert. “The science has been very clear on this topic for years: gray wolves are fully recovered and their comeback should be touted as a success story. Now it’s time we encourage states to set their own guidelines and allow ranchers, farmers, and landowners to protect their livelihoods. I look forward to voting for this bill on the House floor and ultimately getting it to President Trump for his signature.”

    “The Endangered Species Act was never meant to be a Hotel California where species check in but never leave. Congresswoman Boebert and Congressman Tiffany’s Pet and Livestock Protection Act will allow the recovered gray wolf to check out and return management to the states who know the species best. I thank Ms. Boebert and Mr. Tiffany for their work on this important issue,” said Natural Resources Committee Chairman Bruce Westerman.

    “Hunter Nation salutes the House Natural Resources Committee for voting the ‘Pet and Livestock Protection Act’ out of committee, and thanks Congressman Tom Tiffany and Congresswoman Lauren Boebert for their unwavering support of hunters and our hunting lifestyle,” said Keith Mark, President/Founder of Hunter Nation. “The delisting of the gray wolf is a policy change we have been fighting for since our founding. The recovery of the gray wolf is an incredible conservation success story that should be celebrated. This legislation allows each state to manage the now recovered wolf population just as they manage all other wildlife within the state. The best part of this legislation is the provision that prevents judicial review of the legislative action which will preclude anti-hunting groups from using activist judges to interfere with sound, science-based conservation.”

    In 2020, the Department of the Interior and the U.S. Fish and Wildlife Service delisted the gray wolf in the lower 48 United States through a process that included the best science and data available. At over 6,000 wolves at the time of delisting, the gray wolf has been the latestEndangered Species Act success story with significant population recoveries in the Rocky Mountains and western Great Lakes regions. However, despite ample scientific evidence of the gray wolf’s recovery, a California judge unilaterally relisted the gray wolf under the ESA last year. The Pet and Livestock Protection Act requires the Secretary of the Interior to reissue the 2020 Department of the Interior final rule that delisted gray wolves in the lower 48 United States.

    32 Members of Congress cosponsored Rep. Tiffany and Rep. Boebert’s legislation, including the entire Wisconsin Republican Congressional Delegation. 

    Stakeholders that support the Pet and Livestock Protection Act include: Hunter Nation, American Farm Bureau Federation, National Cattlemen’s Beef Association (NCBA), Public Lands Council (PLC), National Rifle Association (NRA), Safari Club International (SCI), International Order of T. Roosevelt (IOTR), Congressional Sportsmen’s Foundation, Mule Deer Foundation, Blacktail Deer Foundation, Colorado Farm Bureau, Colorado Wool Growers, New Mexico Cattle Growers, Minnesota Lamb & Wool Producers Association, Coalition of Arizona/New Mexico Counties, Rocky Mountain Elk Foundation, Wisconsin Farm Bureau Federation, Wisconsin Cattlemen’s Association, Nebraska Cattlemen, and Wisconsin Bear Hunters Association   

    The full text of the Pet and Livestock Protection Act can be found here.

    ###

    MIL OSI USA News –

  • MIL-OSI: Form 8.3 – [ALLIANCE PHARMA PLC – 08 04 2025] – (CGWL)

    Source: GlobeNewswire (MIL-OSI)

    FORM 8.3

    PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY
    A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE
    Rule 8.3 of the Takeover Code (the “Code”)

    1.        KEY INFORMATION

    (a)   Full name of discloser: CANACCORD GENUITY WEALTH LIMITED (for Discretionary clients)
    (b)   Owner or controller of interests and short positions disclosed, if different from 1(a):
            The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.    		 N/A
    (c)   Name of offeror/offeree in relation to whose relevant securities this form relates:
            Use a separate form for each offeror/offeree    		 ALLIANCE PHARMA PLC
    (d)   If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree: N/A
    (e)   Date position held/dealing undertaken:
            For an opening position disclosure, state the latest practicable date prior to the disclosure    		 08 APRIL 2025
    (f)   In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?
            If it is a cash offer or possible cash offer, state “N/A”    		 N/A

    2.        POSITIONS OF THE PERSON MAKING THE DISCLOSURE

    If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

    (a)      Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

    Class of relevant security: 1p ORDINARY
      Interests Short positions
    Number % Number %
    (1)   Relevant securities owned and/or controlled: 11,993,055 2.2186    
    (2)   Cash-settled derivatives:        
    (3)   Stock-settled derivatives (including options) and agreements to purchase/sell:        
    TOTAL: 11,993,055 2.2186    

    All interests and all short positions should be disclosed.

    Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

    (b)      Rights to subscribe for new securities (including directors’ and other employee options)

    Class of relevant security in relation to which subscription right exists:  
    Details, including nature of the rights concerned and relevant percentages:  

    3.        DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

    Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

    The currency of all prices and other monetary amounts should be stated.

    (a)        Purchases and sales

    Class of relevant security Purchase/sale Number of securities Price per unit
    1p ORDINARY SALE 14,000 64.226p
    1p ORDINARY SALE 11,500 64.2261p

    (b)        Cash-settled derivative transactions

    Class of relevant security Product description
    e.g. CFD    		 Nature of dealing
    e.g. opening/closing a long/short position, increasing/reducing a long/short position    		 Number of reference securities Price per unit
    NONE        

    (c)        Stock-settled derivative transactions (including options)

    (i)        Writing, selling, purchasing or varying

    Class of relevant security Product description e.g. call option Writing, purchasing, selling, varying etc. Number of securities to which option relates Exercise price per unit Type
    e.g. American, European etc.    		 Expiry date Option money paid/ received per unit
    NONE              

    (ii)        Exercise

    Class of relevant security Product description
    e.g. call option    		 Exercising/ exercised against Number of securities Exercise price per unit

    (d)        Other dealings (including subscribing for new securities)

    Class of relevant security Nature of dealing
    e.g. subscription, conversion    		 Details Price per unit (if applicable)
    NONE      

    4.        OTHER INFORMATION

    (a)        Indemnity and other dealing arrangements

    Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:
    Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state “none”

    NONE

    (b)        Agreements, arrangements or understandings relating to options or derivatives

    Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to:
    (i)   the voting rights of any relevant securities under any option; or
    (ii)   the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:
    If there are no such agreements, arrangements or understandings, state “none”

    NONE

    (c)        Attachments

    Is a Supplemental Form 8 (Open Positions) attached? NO
    Date of disclosure: 09 APRIL 2025
    Contact name: MARK ELLIOTT
    Telephone number: 01253 376539

    Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

    The Panel’s Market Surveillance Unit is available for consultation in relation to the Code’s disclosure requirements on +44 (0)20 7638 0129.

    The Code can be viewed on the Panel’s website at www.thetakeoverpanel.org.uk.

    The MIL Network –

  • MIL-OSI: Form 8.3 – [ADVANCED MEDICAL SOLUTIONS GROUP PLC – 08 04 2025] – (CGWL)

    Source: GlobeNewswire (MIL-OSI)

    FORM 8.3

    PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY
    A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE
    Rule 8.3 of the Takeover Code (the “Code”)

    1.        KEY INFORMATION

    (a)   Full name of discloser: CANACCORD GENUITY WEALTH LIMITED (for Discretionary clients)
    (b)   Owner or controller of interests and short positions disclosed, if different from 1(a):
            The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.    		 N/A
    (c)   Name of offeror/offeree in relation to whose relevant securities this form relates:
            Use a separate form for each offeror/offeree    		 ADVANCED MEDICAL SOLUTIONS GROUP PLC
    (d)   If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree: N/A
    (e)   Date position held/dealing undertaken:
            For an opening position disclosure, state the latest practicable date prior to the disclosure    		 08 APRIL 2025
    (f)   In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?
            If it is a cash offer or possible cash offer, state “N/A”    		 N/A

    2.        POSITIONS OF THE PERSON MAKING THE DISCLOSURE

    If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

    (a)      Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

    Class of relevant security: 5p ORDINARY
      Interests Short positions
    Number % Number %
    (1)   Relevant securities owned and/or controlled: 11,884,856 5.4510    
    (2)   Cash-settled derivatives:        
    (3)   Stock-settled derivatives (including options) and agreements to purchase/sell:        
    TOTAL: 11,884,856 5.4510    

    All interests and all short positions should be disclosed.

    Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

    (b)      Rights to subscribe for new securities (including directors’ and other employee options)

    Class of relevant security in relation to which subscription right exists:  
    Details, including nature of the rights concerned and relevant percentages:  

    3.        DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

    Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

    The currency of all prices and other monetary amounts should be stated.

    (a)        Purchases and sales

    Class of relevant security Purchase/sale Number of securities Price per unit
    5p ORDINARY SALE 2,775 199.544p
    5p ORDINARY SALE 2,225 200.83p
    5p ORDINARY SALE 990 202.5p

    (b)        Cash-settled derivative transactions

    Class of relevant security Product description
    e.g. CFD    		 Nature of dealing
    e.g. opening/closing a long/short position, increasing/reducing a long/short position    		 Number of reference securities Price per unit
    NONE        

    (c)        Stock-settled derivative transactions (including options)

    (i)        Writing, selling, purchasing or varying

    Class of relevant security Product description e.g. call option Writing, purchasing, selling, varying etc. Number of securities to which option relates Exercise price per unit Type
    e.g. American, European etc.    		 Expiry date Option money paid/ received per unit
    NONE              

    (ii)        Exercise

    Class of relevant security Product description
    e.g. call option    		 Exercising/ exercised against Number of securities Exercise price per unit

    (d)        Other dealings (including subscribing for new securities)

    Class of relevant security Nature of dealing
    e.g. subscription, conversion    		 Details Price per unit (if applicable)
    NONE      

    4.        OTHER INFORMATION

    (a)        Indemnity and other dealing arrangements

    Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:
    Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state “none”

    NONE

    (b)        Agreements, arrangements or understandings relating to options or derivatives

    Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to:
    (i)   the voting rights of any relevant securities under any option; or
    (ii)   the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:
    If there are no such agreements, arrangements or understandings, state “none”

    NONE

    (c)        Attachments

    Is a Supplemental Form 8 (Open Positions) attached? NO
    Date of disclosure: 09 APRIL 2025
    Contact name: MARK ELLIOTT
    Telephone number: 01253 376539

    Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

    The Panel’s Market Surveillance Unit is available for consultation in relation to the Code’s disclosure requirements on +44 (0)20 7638 0129.

    The Code can be viewed on the Panel’s website at www.thetakeoverpanel.org.uk.

    The MIL Network –

  • MIL-OSI: Form 8.3 – [ADVANCED MEDICAL SOLUTIONS GROUP PLC – 08 04 2025] – (CGAML)

    Source: GlobeNewswire (MIL-OSI)

    FORM 8.3

    PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY
    A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE
    Rule 8.3 of the Takeover Code (the “Code”)

    1.        KEY INFORMATION

    (a)   Full name of discloser: CANACCORD GENUITY ASSET MANAGEMENT LIMITED (for Discretionary clients)
    (b)   Owner or controller of interests and short positions disclosed, if different from 1(a):
            The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.    		 N/A
    (c)   Name of offeror/offeree in relation to whose relevant securities this form relates:
            Use a separate form for each offeror/offeree    		 ADVANCED MEDICAL SOLUTIONS GROUP PLC
    (d)   If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree: N/A
    (e)   Date position held/dealing undertaken:
            For an opening position disclosure, state the latest practicable date prior to the disclosure    		 08 APRIL 2025
    (f)   In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?
            If it is a cash offer or possible cash offer, state “N/A”    		 N/A

    2.        POSITIONS OF THE PERSON MAKING THE DISCLOSURE

    If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

    (a)      Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

    Class of relevant security: 5p ORDINARY
      Interests Short positions
    Number % Number %
    (1)   Relevant securities owned and/or controlled: 4,690,000 2.1511    
    (2)   Cash-settled derivatives:        
    (3)   Stock-settled derivatives (including options) and agreements to purchase/sell:        
    TOTAL: 4,690,000 2.1511    

    All interests and all short positions should be disclosed.

    Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

    (b)      Rights to subscribe for new securities (including directors’ and other employee options)

    Class of relevant security in relation to which subscription right exists:  
    Details, including nature of the rights concerned and relevant percentages:  

    3.        DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

    Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

    The currency of all prices and other monetary amounts should be stated.

    (a)        Purchases and sales

    Class of relevant security Purchase/sale Number of securities Price per unit
    5p ORDINARY PURCHASE 40,000 202.4313p

    (b)        Cash-settled derivative transactions

    Class of relevant security Product description
    e.g. CFD    		 Nature of dealing
    e.g. opening/closing a long/short position, increasing/reducing a long/short position    		 Number of reference securities Price per unit
    NONE        

    (c)        Stock-settled derivative transactions (including options)

    (i)        Writing, selling, purchasing or varying

    Class of relevant security Product description e.g. call option Writing, purchasing, selling, varying etc. Number of securities to which option relates Exercise price per unit Type
    e.g. American, European etc.    		 Expiry date Option money paid/ received per unit
    NONE              

    (ii)        Exercise

    Class of relevant security Product description
    e.g. call option    		 Exercising/ exercised against Number of securities Exercise price per unit

    (d)        Other dealings (including subscribing for new securities)

    Class of relevant security Nature of dealing
    e.g. subscription, conversion    		 Details Price per unit (if applicable)
    NONE      

    4.        OTHER INFORMATION

    (a)        Indemnity and other dealing arrangements

    Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:
    Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state “none”

    NONE

    (b)        Agreements, arrangements or understandings relating to options or derivatives

    Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to:
    (i)   the voting rights of any relevant securities under any option; or
    (ii)   the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:
    If there are no such agreements, arrangements or understandings, state “none”

    NONE

    (c)        Attachments

    Is a Supplemental Form 8 (Open Positions) attached? NO
    Date of disclosure: 09 APRIL 2025
    Contact name: MARK ELLIOTT
    Telephone number: 01253 376539

    Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

    The Panel’s Market Surveillance Unit is available for consultation in relation to the Code’s disclosure requirements on +44 (0)20 7638 0129.

    The Code can be viewed on the Panel’s website at www.thetakeoverpanel.org.uk.

    The MIL Network –

  • MIL-OSI: YieldMax™ ETFs Announces Distributions on SMCY (102.27%), MSTY (101.29%), ULTY (78.88%), AIYY (70.96%), LFGY (69.83%), and Others

    Source: GlobeNewswire (MIL-OSI)

    CHICAGO and MILWAUKEE and NEW YORK, April 09, 2025 (GLOBE NEWSWIRE) — YieldMax™ today announced distributions for the YieldMax™ Weekly Payers and Group D ETFs listed in the table below.

    ETF
    Ticker    1    		 ETF Name Distribution
    Frequency    		 Distribution
    per Share    		 Distribution
    Rate    2,4    		 30-Day
    SEC Yield3    		 ROC5 Ex-Date &
    Record Date    		 Payment
    Date
    CHPY* YieldMax™ Semiconductor Portfolio Option Income ETF Weekly – – – – – –
    GPTY YieldMax™ AI & Tech Portfolio Option Income ETF Weekly $0.2360 35.40% 0.00% 0.00% 4/10/25 4/11/25
    LFGY YieldMax™ Crypto Industry & Tech Portfolio Option Income ETF Weekly $0.4170 69.83% 0.00% 0.00% 4/10/25 4/11/25
    QDTY YieldMax™ Nasdaq 100 0DTE Covered Call ETF Weekly $0.2199 29.87% 0.00% 100.00% 4/10/25 4/11/25
    RDTY YieldMax™ R2000 0DTE Covered Call ETF Weekly $0.3590 45.69% 0.00% 100.00% 4/10/25 4/11/25
    SDTY YieldMax™ S&P 500 0DTE Covered Call ETF Weekly $0.2270 29.60% 0.00% 100.00% 4/10/25 4/11/25
    ULTY YieldMax™ Ultra Option Income Strategy ETF Weekly $0.0822 78.88% 2.21% 0.00% 4/10/25 4/11/25
    YMAG YieldMax™ Magnificent 7 Fund of Option Income ETFs Weekly $0.0973 38.00% 69.89% 53.05% 4/10/25 4/11/25
    YMAX YieldMax™ Universe Fund of Option Income ETFs Weekly $0.1289 57.35% 96.57% 64.98% 4/10/25 4/11/25
    AIYY YieldMax™ AI Option Income Strategy ETF Every 4 weeks $0.2301 70.96% 4.89% 93.15% 4/10/25 4/11/25
    AMZY YieldMax™ AMZN Option Income Strategy ETF Every 4 weeks $0.4877 43.54% 4.40% 89.31% 4/10/25 4/11/25
    APLY YieldMax™ AAPL Option Income Strategy ETF Every 4 weeks $0.3023 33.00% 3.44% 44.35% 4/10/25 4/11/25
    DISO YieldMax™ DIS Option Income Strategy ETF Every 4 weeks $0.3254 35.32% 4.03% 0.00% 4/10/25 4/11/25
    MSTY YieldMax™ MSTR Option Income Strategy ETF Every 4 weeks $1.3356 101.29% 0.50% 0.48% 4/10/25 4/11/25
    SMCY YieldMax™ SMCI Option Income Strategy ETF Every 4 weeks $1.5012 102.27% 3.01% 67.02% 4/10/25 4/11/25
    WNTR** YieldMax™ Short MSTR Option Income Strategy ETF Every 4 weeks – – – – – –
    XYZY YieldMax™ XYZ Option Income Strategy ETF Every 4 weeks $0.4412 59.61% 6.32% 89.82% 4/10/25 4/11/25
    YQQQ YieldMax™ Short N100 Option Income Strategy ETF Every 4 weeks $0.4437 30.86% 3.08% 0.00% 4/10/25 4/11/25
    Weekly Payers & Group A ETFs scheduled for next week: CHPY GPTY LFGY QDTY RDTY SDTY UTLY YMAG YMAX CRSH FEAT FIVY GOOY OARK SNOY TSLY TSMY XOMO YBIT


    Performance data quoted represents past performance and is no guarantee of future results. Investment return and principal value of an investment will fluctuate so that an investor’s shares, when sold or redeemed, may be worth more or less than their original cost and current performance may be lower or higher than the performance quoted above. Performance current to the most recent month-end can be obtained by calling     (833) 378-0717.

    Note: DIPS, FIAT, CRSH, YQQQ and WNTR are hereinafter referred to as the “Short ETFs.”

    Distributions are not guaranteed. The Distribution Rate and 30-Day SEC Yield are not indicative of future distributions, if any, on the ETFs. In particular, future distributions on any ETF may differ significantly from its Distribution Rate or 30-Day SEC Yield. You are not guaranteed a distribution under the ETFs. Distributions for the ETFs (if any) are variable and may vary significantly from period to period and may be zero. Accordingly, the Distribution Rate and 30-Day SEC Yield will change over time, and such change may be significant.

    Investors in the Funds will not have rights to receive dividends or other distributions with respect to the underlying reference asset(s).

    *The inception date for CHPY is April 2, 2025.

    **The inception date for WNTR is March 26, 2025.

    1 All YieldMax™ ETFs shown in the table above (except YMAX, YMAG, FEAT, FIVY and ULTY) have a gross expense ratio of 0.99%. YMAX, YMAG and FEAT have a Management Fee of 0.29% and Acquired Fund Fees and Expenses of 0.99% for a gross expense ratio of 1.28%. FIVY has a Management Fee of 0.29% and Acquired Fund Fees and Expenses of 0.59% for a gross expense ratio of 0.88%. “Acquired Fund Fees and Expenses” are indirect fees and expenses that the Fund incurs from investing in the shares of other investment companies, namely other YieldMax™ ETFs. ULTY has a gross expense ratio after the fee waiver of 1.30%. The Advisor has agreed to a fee waiver of 0.10% through at least February 28, 2026.
    2 The Distribution Rate shown is as of close on April 8, 2025. The Distribution Rate is the annual distribution rate an investor would receive if the most recent distribution, which includes option income, remained the same going forward. The Distribution Rate is calculated by annualizing an ETF’s Distribution per Share and dividing such annualized amount by the ETF’s most recent NAV. The Distribution Rate represents a single distribution from the ETF and does not represent its total return. Distributions may also include a combination of ordinary dividends, capital gain, and return of investor capital, which may decrease an ETF’s NAV and trading price over time. As a result, an investor may suffer significant losses to their investment. These Distribution Rates may be caused by unusually favorable market conditions and may not be sustainable. Such conditions may not continue to exist and there should be no expectation that this performance may be repeated in the future.
    3 The 30-Day SEC Yield represents net investment income, which excludes option income, earned by such ETF over the 30-Day period ended March 31, 2025, expressed as an annual percentage rate based on such ETF’s share price at the end of the 30-Day period.
    4 Each ETF’s strategy (except those of the Short ETFs) will cap potential gains if its reference asset’s shares increase in value, yet subjects an investor to all potential losses if the reference asset’s shares decrease in value. Such potential losses may not be offset by income received by the ETF. Each Short ETF’s strategy will cap potential gains if its reference asset decreases in value, yet subjects an investor to all potential losses if the reference asset increases in value. Such potential losses may not be offset by income received by the ETF.
    5 ROC refers to Return of Capital. The ROC percentage is the portion of the distribution that represents an investor’s original investment.


    Each Fund has a limited operating history and while each Fund’s objective is to provide current income, there is no guarantee the Fund will make a distribution. Distributions are likely to vary greatly in amount.

    Standardized Performance

    For YMAX, click here. For YMAG, click here. For TSLY, click here. For OARK, click here. For APLY, click here. For NVDY, click here. For AMZY, click here. For FBY, click here. For GOOY, click here. For NFLY, click here. For CONY, click here. For MSFO, click here. For DISO, click here. For XOMO, click here. For JPMO, click here. For AMDY, click here. For PYPY, click here. For XYZY, click here. For MRNY, click here. For AIYY, click here. For MSTY, click here. For ULTY, click here. For YBIT, click here. For CRSH, click here. For GDXY, click here. For SNOY, click here. For ABNY, click here. For FIAT, click here. For DIPS, click here. For BABO, click here. For YQQQ, click here. For TSMY, click here. For SMCY, click here. For PLTY, click here. For BIGY, click here. For SOXY, click here. For MARO, click here. For FEAT, click here. For FIVY, click here. For LFGY, click here. For GPTY, click here. For CVNY, click here. For SDTY, click here. For QDTY, click here. For WNTR, click here. For CHPY, click here

    Important Information

    This material must be preceded or accompanied by the prospectus. For all prospectuses, click here.

    Tidal Financial Group is the adviser for all YieldMax™ ETFs.

    THE FUND, TRUST, AND ADVISER ARE NOT AFFILIATED WITH ANY UNDERLYING REFERENCE ASSET.

    Risk Disclosures (applicable to all YieldMax ETFs referenced above, except the Short ETFs)

    YMAX, YMAG, FEAT and FIVY generally invest in other YieldMax™ ETFs. As such, these two Funds are subject to the risks listed in this section, which apply to all the YieldMax™ ETFs they may hold from time to time.

    Investing involves risk. Principal loss is possible.

    Referenced Index Risk. The Fund invests in options contracts that are based on the value of the Index (or the Index ETFs). This subjects the Fund to certain of the same risks as if it owned shares of companies that comprised the Index or an ETF that tracks the Index, even though it does not.

    Indirect Investment Risk. The Index is not affiliated with the Trust, the Fund, the Adviser, or their respective affiliates and is not involved with this offering in any way. Investors in the Fund will not have the right to receive dividends or other distributions or any other rights with respect to the companies that comprise the Index but will be subject to declines in the performance of the Index.

    Russell 2000 Index Risks. The Index, which consists of small-cap U.S. companies, is particularly susceptible to economic changes, as these firms often have less financial resilience than larger companies. Market volatility can disproportionately affect these smaller businesses, leading to significant price swings. Additionally, these companies are often more exposed to specific industry risks and have less diverse revenue streams. They can also be more vulnerable to changes in domestic regulatory or policy environments.

    Call Writing Strategy Risk. The path dependency (i.e., the continued use) of the Fund’s call writing strategy will impact the extent that the Fund participates in the positive price returns of the underlying reference asset and, in turn, the Fund’s returns, both during the term of the sold call options and over longer periods.

    Counterparty Risk. The Fund is subject to counterparty risk by virtue of its investments in options contracts. Transactions in some types of derivatives, including options, are required to be centrally cleared (“cleared derivatives”). In a transaction involving cleared derivatives, the Fund’s counterparty is a clearing house rather than a bank or broker. Since the Fund is not a member of clearing houses and only members of a clearing house (“clearing members”) can participate directly in the clearing house, the Fund will hold cleared derivatives through accounts at clearing members.

    Derivatives Risk. Derivatives are financial instruments that derive value from the underlying reference asset or assets, such as stocks, bonds, or funds (including ETFs), interest rates or indexes. The Fund’s investments in derivatives may pose risks in addition to, and greater than, those associated with directly investing in securities or other ordinary investments, including risk related to the market, imperfect correlation with underlying investments or the Fund’s other portfolio holdings, higher price volatility, lack of availability, counterparty risk, liquidity, valuation and legal restrictions.

    Options Contracts. The use of options contracts involves investment strategies and risks different from those associated with ordinary portfolio securities transactions. The prices of options are volatile and are influenced by, among other things, actual and anticipated changes in the value of the underlying instrument, including the anticipated volatility, which are affected by fiscal and monetary policies and by national and international political, changes in the actual or implied volatility or the reference asset, the time remaining until the expiration of the option contract and economic events.

    Distribution Risk. As part of the Fund’s investment objective, the Fund seeks to provide current income. There is no assurance that the Fund will make a distribution in any given period. If the Fund does make distributions, the amounts of such distributions will likely vary greatly from one distribution to the next.

    High Portfolio Turnover Risk. The Fund may actively and frequently trade all or a significant portion of the Fund’s holdings. A high portfolio turnover rate increases transaction costs, which may increase the Fund’s expenses.

    Liquidity Risk. Some securities held by the Fund, including options contracts, may be difficult to sell or be illiquid, particularly during times of market turmoil.

    Non-Diversification Risk. Because the Fund is “non-diversified,” it may invest a greater percentage of its assets in the securities of a single issuer or a smaller number of issuers than if it was a diversified fund.

    New Fund Risk. The Fund is a recently organized management investment company with no operating history. As a result, prospective investors do not have a track record or history on which to base their investment decisions.

    Price Participation Risk. The Fund employs an investment strategy that includes the sale of call option contracts, which limits the degree to which the Fund will participate in increases in value experienced by the underlying reference asset over the Call Period.

    Single Issuer Risk. Issuer-specific attributes may cause an investment in the Fund to be more volatile than a traditional pooled investment which diversifies risk or the market generally. The value of the Fund, which focuses on an individual security (ARKK, TSLA, AAPL, NVDA, AMZN, META, GOOGL, NFLX, COIN, MSFT, DIS, XOM, JPM, AMD, PYPL, SQ, MRNA, AI, MSTR, Bitcoin ETP, GDX®, SNOW, ABNB, BABA, TSM, SMCI, PLTR, MARA, CVNA), may be more volatile than a traditional pooled investment or the market as a whole and may perform differently from the value of a traditional pooled investment or the market as a whole.

    Inflation Risk. Inflation risk is the risk that the value of assets or income from investments will be less in the future as inflation decreases the value of money. As inflation increases, the present value of the Fund’s assets and distributions, if any, may decline.

    Indirect Investment Risk. The Index is not affiliated with the Trust, the Fund, the Adviser, or their respective affiliates and is not involved with this offering in any way.

    Risk Disclosures (applicable only to GPTY)

    Artificial Intelligence Risk. Issuers engaged in artificial intelligence typically have high research and capital expenditures and, as a result, their profitability can vary widely, if they are profitable at all. The space in which they are engaged is highly competitive and issuers’ products and services may become obsolete very quickly. These companies are heavily dependent on intellectual property rights and may be adversely affected by loss or impairment of those rights. The issuers are also subject to legal, regulatory, and political changes that may have a large impact on their profitability. A failure in an issuer’s product or even questions about the safety of the product could be devastating to the issuer, especially if it is the marquee product of the issuer. It can be difficult to accurately capture what qualifies as an artificial intelligence company.

    Technology Sector Risk. The Fund will invest substantially in companies in the information technology sector, and therefore the performance of the Fund could be negatively impacted by events affecting this sector. Market or economic factors impacting technology companies and companies that rely heavily on technological advances could have a significant effect on the value of the Fund’s investments. The value of stocks of information technology companies and companies that rely heavily on technology is particularly vulnerable to rapid changes in technology product cycles, rapid product obsolescence, government regulation and competition, both domestically and internationally, including competition from foreign competitors with lower production costs. Stocks of information technology companies and companies that rely heavily on technology, especially those of smaller, less-seasoned companies, tend to be more volatile than the overall market. Information technology companies are heavily dependent on patent and intellectual property rights, the loss or impairment of which may adversely affect profitability.

    Risk Disclosure (applicable only to MARO)

    Digital Assets Risk: The Fund does not invest directly in Bitcoin or any other digital assets. The Fund does not invest directly in derivatives that track the performance of Bitcoin or any other digital assets. The Fund does not invest in or seek direct exposure to the current “spot” or cash price of Bitcoin. Investors seeking direct exposure to the price of Bitcoin should consider an investment other than the Fund. Digital assets like Bitcoin, designed as mediums of exchange, are still an emerging asset class. They operate independently of any central authority or government backing and are subject to regulatory changes and extreme price volatility.

    Risk Disclosures (applicable only to BABO and TSMY)

    Currency Risk: Indirect exposure to foreign currencies subjects the Fund to the risk that currencies will decline in value relative to the U.S. dollar. Currency rates in foreign countries may fluctuate significantly over short periods of time for a number of reasons, including changes in interest rates and the imposition of currency controls or other political developments in the U.S. or abroad.

    Depositary Receipts Risk: The securities underlying BABO and TSMY are American Depositary Receipts (“ADRs”). Investment in ADRs may be less liquid than the underlying shares in their primary trading market.

    Foreign Market and Trading Risk: The trading markets for many foreign securities are not as active as U.S. markets and may have less governmental regulation and oversight.

    Foreign Securities Risk: Investments in securities of non-U.S. issuers involve certain risks that may not be present with investments in securities of U.S. issuers, such as risk of loss due to foreign currency fluctuations or to political or economic instability, as well as varying regulatory requirements applicable to investments in non-U.S. issuers. There may be less information publicly available about a non-U.S. issuer than a U.S. issuer. Non-U.S. issuers may also be subject to different regulatory, accounting, auditing, financial reporting, and investor protection standards than U.S. issuers.

    Risk Disclosures (applicable only to GDXY)

    Risk of Investing in Foreign Securities. The Fund is exposed indirectly to the securities of foreign issuers selected by GDX®’s investment adviser, which subjects the Fund to the risks associated with such companies. Investments in the securities of foreign issuers involve risks beyond those associated with investments in U.S. securities.

    Risk of Investing in Gold and Silver Mining Companies. The Fund is exposed indirectly to gold and silver mining companies selected by GDX®’s investment adviser, which subjects the Fund to the risks associated with such companies.

    The Fund invests in options contracts based on the value of the VanEck Gold Miners ETF (GDX®), which subjects the Fund to some of the same risks as if it owned GDX®, as well as the risks associated with Canadian, Australian and Emerging Market Issuers, and Small-and Medium-Capitalization companies.

    Risk Disclosures (applicable only to YBIT)

    YBIT does not invest directly in Bitcoin or any other digital assets. YBIT does not invest directly in derivatives that track the performance of Bitcoin or any other digital assets. YBIT does not invest in or seek direct exposure to the current “spot” or cash price of Bitcoin. Investors seeking direct exposure to the price of Bitcoin should consider an investment other than YBIT.

    Bitcoin Investment Risk: The Fund’s indirect investment in Bitcoin, through holdings in one or more Underlying ETPs, exposes it to the unique risks of this emerging innovation. Bitcoin’s price is highly volatile, and its market is influenced by the changing Bitcoin network, fluctuating acceptance levels, and unpredictable usage trends.

    Digital Assets Risk: Digital assets like Bitcoin, designed as mediums of exchange, are still an emerging asset class. They operate independently of any central authority or government backing and are subject to regulatory changes and extreme price volatility. Potentially No 1940 Act Protections. As of the date of this Prospectus, there is only a single eligible Underlying ETP, and it is an investment company subject to the 1940 Act.

    Bitcoin ETP Risk: The Fund invests in options contracts that are based on the value of the Bitcoin ETP. This subjects the Fund to certain of the same risks as if it owned shares of the Bitcoin ETP, even though it does not. Bitcoin ETPs are subject, but not limited, to significant risk and heightened volatility. An investor in a Bitcoin ETP may lose their entire investment. Bitcoin ETPs are not suitable for all investors. In addition, not all Bitcoin ETPs are registered under the Investment Company Act of 1940. Those Bitcoin ETPs that are not registered under such statute are therefore not subject to the same regulations as exchange traded products that are so registered.

    Risk Disclosures (applicable only to the Short ETFs)

    Investing involves risk. Principal loss is possible.

    Price Appreciation Risk. As part of the Fund’s synthetic covered put strategy, the Fund purchases and sells call and put option contracts that are based on the value of the underlying reference asset. This strategy subjects the Fund to certain of the same risks as if it shorted the underlying reference asset, even though it does not. By virtue of the Fund’s indirect inverse exposure to changes in the value of the underlying reference asset, the Fund is subject to the risk that the value of the underlying reference asset increases. If the value of the underlying reference asset increases, the Fund will likely lose value and, as a result, the Fund may suffer significant losses.

    Put Writing Strategy Risk. The path dependency (i.e., the continued use) of the Fund’s put writing (selling) strategy will impact the extent that the Fund participates in decreases in the value of the underlying reference asset and, in turn, the Fund’s returns, both during the term of the sold put options and over longer periods.

    Purchased OTM Call Options Risk. The Fund’s strategy is subject to potential losses if the underlying reference asset increases in value, which may not be offset by the purchase of out-of-the-money (OTM) call options. The Fund purchases OTM calls to seek to manage (cap) the Fund’s potential losses from the Fund’s short exposure to the underlying reference asset if it appreciates significantly in value. However, the OTM call options will cap the Fund’s losses only to the extent that the value of the underlying reference asset increases to a level that is at or above the strike level of the purchased OTM call options. Any increase in the value of the underlying reference asset to a level that is below the strike level of the purchased OTM call options will result in a corresponding loss for the Fund. For example, if the OTM call options have a strike level that is approximately 100% above the then-current value of the underlying reference asset at the time of the call option purchase, and the value of the underlying reference asset increases by at least 100% during the term of the purchased OTM call options, the Fund will lose all its value. Since the Fund bears the costs of purchasing the OTM calls, such costs will decrease the Fund’s value and/or any income otherwise generated by the Fund’s investment strategy.

    Counterparty Risk. The Fund is subject to counterparty risk by virtue of its investments in options contracts. Transactions in some types of derivatives, including options, are required to be centrally cleared (“cleared derivatives”). In a transaction involving cleared derivatives, the Fund’s counterparty is a clearing house rather than a bank or broker. Since the Fund is not a member of clearing houses and only members of a clearing house (“clearing members”) can participate directly in the clearing house, the Fund will hold cleared derivatives through accounts at clearing members.

    Derivatives Risk. Derivatives are financial instruments that derive value from the underlying reference asset or assets, such as stocks, bonds, or funds (including ETFs), interest rates or indexes. The Fund’s investments in derivatives may pose risks in addition to, and greater than, those associated with directly investing in securities or other ordinary investments, including risk related to the market, imperfect correlation with underlying investments or the Fund’s other portfolio holdings, higher price volatility, lack of availability, counterparty risk, liquidity, valuation and legal restrictions.

    Options Contracts. The use of options contracts involves investment strategies and risks different from those associated with ordinary portfolio securities transactions. The prices of options are volatile and are influenced by, among other things, actual and anticipated changes in the value of the underlying reference asset, including the anticipated volatility, which are affected by fiscal and monetary policies and by national and international political, changes in the actual or implied volatility or the reference asset, the time remaining until the expiration of the option contract and economic events.

    Distribution Risk. As part of the Fund’s investment objective, the Fund seeks to provide current income. There is no assurance that the Fund will make a distribution in any given period. If the Fund does make distributions, the amounts of such distributions will likely vary greatly from one distribution to the next.

    High Portfolio Turnover Risk. The Fund may actively and frequently trade all or a significant portion of the Fund’s holdings.

    Liquidity Risk. Some securities held by the Fund, including options contracts, may be difficult to sell or be illiquid, particularly during times of market turmoil.

    Non-Diversification Risk. Because the Fund is “non-diversified,” it may invest a greater percentage of its assets in the securities of a single issuer or a smaller number of issuers than if it was a diversified fund.

    New Fund Risk. The Fund is a recently organized management investment company with no operating history. As a result, prospective investors do not have a track record or history on which to base their investment decisions.

    Price Participation Risk. The Fund employs an investment strategy that includes the sale of put option contracts, which limits the degree to which the Fund will participate in decreases in value experienced by the underlying reference asset over the Put Period.

    Single Issuer Risk. Issuer-specific attributes may cause an investment in the Fund to be more volatile than a traditional pooled investment which diversifies risk or the market generally. The value of the Fund, for any Fund that focuses on an individual security (e.g., TSLA, COIN, NVDA, MSTR), may be more volatile than a traditional pooled investment or the market as a whole and may perform differently from the value of a traditional pooled investment or the market as a whole.

    Inflation Risk. Inflation risk is the risk that the value of assets or income from investments will be less in the future as inflation decreases the value of money. As inflation increases, the present value of the Fund’s assets and distributions, if any, may decline.

    Risk Disclosures (applicable only to CHPY)

    Semiconductor Industry Risk. Semiconductor companies may face intense competition, both domestically and internationally, and such competition may have an adverse effect on their profit margins. Semiconductor companies may have limited product lines, markets, financial resources or personnel. Semiconductor companies’ supply chain and operations are dependent on the availability of materials that meet exacting standards and the use of third parties to provide components and services.

    The products of semiconductor companies may face obsolescence due to rapid technological developments and frequent new product introduction, unpredictable changes in growth rates and competition for the services of qualified personnel. Capital equipment expenditures could be substantial, and equipment generally suffers from rapid obsolescence. Companies in the semiconductor industry are heavily dependent on patent and intellectual property rights. The loss or impairment of these rights would adversely affect the profitability of these companies.

    Risk Disclosures (applicable only to YQQQ)

    Index Overview. The Nasdaq 100 Index is a benchmark index that includes 100 of the largest non-financial companies listed on the Nasdaq Stock Market, based on market capitalization.

    Index Level Appreciation Risk. As part of the Fund’s synthetic covered put strategy, the Fund purchases and sells call and put option contracts that are based on the Index level. This strategy subjects the Fund to certain of the same risks as if it shorted the Index, even though it does not. By virtue of the Fund’s indirect inverse exposure to changes in the Index level, the Fund is subject to the risk that the Index level increases. If the Index level increases, the Fund will likely lose value and, as a result, the Fund may suffer significant losses. The Fund may also be subject to the following risks: innovation and technological advancement; strong market presence of Index constituent companies; adaptability to global market trends; and resilience and recovery potential.

    Index Level Participation Risk. The Fund employs an investment strategy that includes the sale of put option contracts, which limits the degree to which the Fund will benefit from decreases in the Index level experienced over the Put Period. This means that if the Index level experiences a decrease in value below the strike level of the sold put options during a Put Period, the Fund will likely not experience that increase to the same extent and any Fund gains may significantly differ from the level of the Index losses over the Put Period. Additionally, because the Fund is limited in the degree to which it will participate in decreases in value experienced by the Index level over each Put Period, but has significant negative exposure to any increases in value experienced by the Index level over the Put Period, the NAV of the Fund may decrease over any given period. The Fund’s NAV is dependent on the value of each options portfolio, which is based principally upon the inverse of the performance of the Index level. The Fund’s ability to benefit from the Index level decreases will depend on prevailing market conditions, especially market volatility, at the time the Fund enters into the sold put option contracts and will vary from Put Period to Put Period. The value of the options contracts is affected by changes in the value and dividend rates of component companies that comprise the Index, changes in interest rates, changes in the actual or perceived volatility of the Index and the remaining time to the options’ expiration, as well as trading conditions in the options market. As the Index level changes and time moves towards the expiration of each Put Period, the value of the options contracts, and therefore the Fund’s NAV, will change. However, it is not expected for the Fund’s NAV to directly inversely correlate on a day-to-day basis with the returns of the Index level. The amount of time remaining until the options contract’s expiration date affects the impact that the value of the options contracts has on the Fund’s NAV, which may not be in full effect until the expiration date of the Fund’s options contracts. Therefore, while changes in the Index level will result in changes to the Fund’s NAV, the Fund generally anticipates that the rate of change in the Fund’s NAV will be different than the inverse of the changes experienced by the Index level.

    YieldMax™ ETFs are distributed by Foreside Fund Services, LLC. Foreside is not affiliated with Tidal Financial Group, or YieldMax™ ETFs.

    © 2025 YieldMax™ ETFs

    The MIL Network –

  • MIL-OSI: Max Alderman, Partner at FE International, Recognized as a NACVA 2024 30 Under Thirty Honoree

    Source: GlobeNewswire (MIL-OSI)

    NEW YORK, April 08, 2025 (GLOBE NEWSWIRE) — FE International, a leading M&A advisory firm, is pleased to announce that Max Alderman, Partner at FE International, has been recognized by the National Association of Certified Valuators and Analysts® (NACVA®) as a 2024 30 Under Thirty honoree.

    The NACVA 30 Under Thirty program spotlights rising professionals in the business valuation, financial forensics, or related profession that are thirty or under who embodies the drive, motivation, and courage needed to be part of the next generation of industry mavericks.

    Max Alderman has more than eight years of experience advising on TMT M&A transactions, advising on more than $7 billion in transaction value. As a technology investment banker, he has led complex cross-border deals, managed global deal teams, and built deep relationships with founders, private equity firms, and strategic acquirers. Prior to joining FE International, Max worked in the investment banking groups at Bank of America Merrill Lynch and J.P. Morgan, advising on M&A transactions across the technology sector.

    “I’m honoured to be recognised by NACVA as part of the 2024 30 Under Thirty. It’s a privilege to contribute to the M&A space alongside so many talented professionals, and I’m excited to continue pushing boundaries, creating value, and learning from the best in the industry,” said Max Alderman, Partner at FE International.

    FE International congratulates Max and the broader community of NACVA honorees.

    About FE International

    Founded in 2010, FE International is an award-winning strategic advisor for technology businesses. The firm’s team has completed over 1,500 transactions with a combined value exceeding $50 billion. FE International has been recognized as one of The Americas’ Fastest Growing Companies by the Financial Times from 2020 to 2024 and has earned a place on the Inc. 5000 list for four consecutive years.

    About NACVA
    The National Association of Certified Valuators and Analysts® (NACVA®) supports the business valuation, financial forensics, and litigation consulting professions. With thousands of members worldwide, NACVA is dedicated to excellence, innovation, and the advancement of its credentialed professionals. The 30 Under Thirty program recognizes the next generation of industry leaders making significant contributions to the field early in their careers.

    Media Contact

    Gaj Tanwar
    Marketing Coordinator, FE International
    Email: gaj.tanwar@feinternational.com

    The MIL Network –

  • MIL-OSI: Form 8.3 – [PURETECH HEALTH PLC – Opening Disclosure – 07 04 2025] – (CGAML)

    Source: GlobeNewswire (MIL-OSI)

    FORM 8.3

    PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY
    A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE
    Rule 8.3 of the Takeover Code (the “Code”)

    1.        KEY INFORMATION

    (a)   Full name of discloser: CANACCORD GENUITY ASSET MANAGEMENT LIMITED (for Discretionary clients)
    (b)   Owner or controller of interests and short positions disclosed, if different from 1(a):
            The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.    		 N/A
    (c)   Name of offeror/offeree in relation to whose relevant securities this form relates:
            Use a separate form for each offeror/offeree    		 PURETECH HEALTH PLC
    (d)   If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree: N/A
    (e)   Date position held/dealing undertaken:
            For an opening position disclosure, state the latest practicable date prior to the disclosure    		 07 APRIL 2025
    (f)   In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?
            If it is a cash offer or possible cash offer, state “N/A”    		 N/A

    2.        POSITIONS OF THE PERSON MAKING THE DISCLOSURE

    If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

    (a)      Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

    Class of relevant security: 1p ORDINARY
      Interests Short positions
    Number % Number %
    (1)   Relevant securities owned and/or controlled: 3,252,362 1.3541    
    (2)   Cash-settled derivatives:        
    (3)   Stock-settled derivatives (including options) and agreements to purchase/sell:        
    TOTAL: 3,252,362 1.3541    

    All interests and all short positions should be disclosed.

    Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

    (b)      Rights to subscribe for new securities (including directors’ and other employee options)

    Class of relevant security in relation to which subscription right exists:  
    Details, including nature of the rights concerned and relevant percentages:  

    3.        DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

    Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

    The currency of all prices and other monetary amounts should be stated.

    (a)        Purchases and sales

    Class of relevant security Purchase/sale Number of securities Price per unit
    None      

    (b)        Cash-settled derivative transactions

    Class of relevant security Product description
    e.g. CFD    		 Nature of dealing
    e.g. opening/closing a long/short position, increasing/reducing a long/short position    		 Number of reference securities Price per unit
    NONE        

    (c)        Stock-settled derivative transactions (including options)

    (i)        Writing, selling, purchasing or varying

    Class of relevant security Product description e.g. call option Writing, purchasing, selling, varying etc. Number of securities to which option relates Exercise price per unit Type
    e.g. American, European etc.    		 Expiry date Option money paid/ received per unit
    NONE              

    (ii)        Exercise

    Class of relevant security Product description
    e.g. call option    		 Exercising/ exercised against Number of securities Exercise price per unit

    (d)        Other dealings (including subscribing for new securities)

    Class of relevant security Nature of dealing
    e.g. subscription, conversion    		 Details Price per unit (if applicable)
    NONE      

    4.        OTHER INFORMATION

    (a)        Indemnity and other dealing arrangements

    Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:
    Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state “none”

    NONE

    (b)        Agreements, arrangements or understandings relating to options or derivatives

    Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to:
    (i)   the voting rights of any relevant securities under any option; or
    (ii)   the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:
    If there are no such agreements, arrangements or understandings, state “none”

    NONE

    (c)        Attachments

    Is a Supplemental Form 8 (Open Positions) attached? NO
    Date of disclosure: 08 APRIL 2025
    Contact name: MARK ELLIOTT
    Telephone number: 01253 376539

    Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

    The Panel’s Market Surveillance Unit is available for consultation in relation to the Code’s disclosure requirements on +44 (0)20 7638 0129.

    The Code can be viewed on the Panel’s website at www.thetakeoverpanel.org.uk.

    The MIL Network –

  • MIL-OSI: Form 8.3 – [ADVANCED MEDICAL SOLUTIONS GROUP PLC – 07 04 2025] – (CGWL)

    Source: GlobeNewswire (MIL-OSI)

    FORM 8.3

    PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY
    A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE
    Rule 8.3 of the Takeover Code (the “Code”)

    1.        KEY INFORMATION

    (a)   Full name of discloser: CANACCORD GENUITY WEALTH LIMITED (for Discretionary clients)
    (b)   Owner or controller of interests and short positions disclosed, if different from 1(a):
            The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.    		 N/A
    (c)   Name of offeror/offeree in relation to whose relevant securities this form relates:
            Use a separate form for each offeror/offeree    		 ADVANCED MEDICAL SOLUTIONS GROUP PLC
    (d)   If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree: N/A
    (e)   Date position held/dealing undertaken:
            For an opening position disclosure, state the latest practicable date prior to the disclosure    		 07 APRIL 2025
    (f)   In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?
            If it is a cash offer or possible cash offer, state “N/A”    		 N/A

    2.        POSITIONS OF THE PERSON MAKING THE DISCLOSURE

    If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

    (a)      Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

    Class of relevant security: 5p ORDINARY
      Interests Short positions
    Number % Number %
    (1)   Relevant securities owned and/or controlled: 11,890,846 5.4538    
    (2)   Cash-settled derivatives:        
    (3)   Stock-settled derivatives (including options) and agreements to purchase/sell:        
    TOTAL: 11,890,846 5.4538    

    All interests and all short positions should be disclosed.

    Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

    (b)      Rights to subscribe for new securities (including directors’ and other employee options)

    Class of relevant security in relation to which subscription right exists:  
    Details, including nature of the rights concerned and relevant percentages:  

    3.        DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

    Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

    The currency of all prices and other monetary amounts should be stated.

    (a)        Purchases and sales

    Class of relevant security Purchase/sale Number of securities Price per unit
    5p ORDINARY SALE 2,820 197.3p
    5p ORDINARY SALE 8,636 198.3p
    5p ORDINARY SALE 1,925 198.9966p
    5p ORDINARY SALE 2,000 199.05p
    5p ORDINARY SALE 2,000 200.35p
    5p ORDINARY PURCHASE 2,820 197.4494p
    5p ORDINARY PURCHASE 8,636 198.3606p

    (b)        Cash-settled derivative transactions

    Class of relevant security Product description
    e.g. CFD    		 Nature of dealing
    e.g. opening/closing a long/short position, increasing/reducing a long/short position    		 Number of reference securities Price per unit
    NONE        

    (c)        Stock-settled derivative transactions (including options)

    (i)        Writing, selling, purchasing or varying

    Class of relevant security Product description e.g. call option Writing, purchasing, selling, varying etc. Number of securities to which option relates Exercise price per unit Type
    e.g. American, European etc.    		 Expiry date Option money paid/ received per unit
    NONE              

    (ii)        Exercise

    Class of relevant security Product description
    e.g. call option    		 Exercising/ exercised against Number of securities Exercise price per unit

    (d)        Other dealings (including subscribing for new securities)

    Class of relevant security Nature of dealing
    e.g. subscription, conversion    		 Details Price per unit (if applicable)
    NONE      

    4.        OTHER INFORMATION

    (a)        Indemnity and other dealing arrangements

    Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:
    Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state “none”

    NONE

    (b)        Agreements, arrangements or understandings relating to options or derivatives

    Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to:
    (i)   the voting rights of any relevant securities under any option; or
    (ii)   the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:
    If there are no such agreements, arrangements or understandings, state “none”

    NONE

    (c)        Attachments

    Is a Supplemental Form 8 (Open Positions) attached? NO
    Date of disclosure: 08 APRIL 2025
    Contact name: MARK ELLIOTT
    Telephone number: 01253 376539

    Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

    The Panel’s Market Surveillance Unit is available for consultation in relation to the Code’s disclosure requirements on +44 (0)20 7638 0129.

    The Code can be viewed on the Panel’s website at www.thetakeoverpanel.org.uk.

    The MIL Network –

  • MIL-OSI: Form 8.3 – [ALLIANCE PHARMA PLC – 07 04 2025] – (CGWL)

    Source: GlobeNewswire (MIL-OSI)

    FORM 8.3

    PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY
    A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE
    Rule 8.3 of the Takeover Code (the “Code”)

    1.        KEY INFORMATION

    (a)   Full name of discloser: CANACCORD GENUITY WEALTH LIMITED (for Discretionary clients)
    (b)   Owner or controller of interests and short positions disclosed, if different from 1(a):
            The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.    		 N/A
    (c)   Name of offeror/offeree in relation to whose relevant securities this form relates:
            Use a separate form for each offeror/offeree    		 ALLIANCE PHARMA PLC
    (d)   If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree: N/A
    (e)   Date position held/dealing undertaken:
            For an opening position disclosure, state the latest practicable date prior to the disclosure    		 07 APRIL 2025
    (f)   In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?
            If it is a cash offer or possible cash offer, state “N/A”    		 N/A

    2.        POSITIONS OF THE PERSON MAKING THE DISCLOSURE

    If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

    (a)      Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

    Class of relevant security: 1p ORDINARY
      Interests Short positions
    Number % Number %
    (1)   Relevant securities owned and/or controlled: 12,018,555 2.2233    
    (2)   Cash-settled derivatives:        
    (3)   Stock-settled derivatives (including options) and agreements to purchase/sell:        
    TOTAL: 12,018,555 2.2233    

    All interests and all short positions should be disclosed.

    Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

    (b)      Rights to subscribe for new securities (including directors’ and other employee options)

    Class of relevant security in relation to which subscription right exists:  
    Details, including nature of the rights concerned and relevant percentages:  

    3.        DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

    Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

    The currency of all prices and other monetary amounts should be stated.

    (a)        Purchases and sales

    Class of relevant security Purchase/sale Number of securities Price per unit
    1p ORDINARY SALE 7,000 64.252p

    (b)        Cash-settled derivative transactions

    Class of relevant security Product description
    e.g. CFD    		 Nature of dealing
    e.g. opening/closing a long/short position, increasing/reducing a long/short position    		 Number of reference securities Price per unit
    NONE        

    (c)        Stock-settled derivative transactions (including options)

    (i)        Writing, selling, purchasing or varying

    Class of relevant security Product description e.g. call option Writing, purchasing, selling, varying etc. Number of securities to which option relates Exercise price per unit Type
    e.g. American, European etc.    		 Expiry date Option money paid/ received per unit
    NONE              

    (ii)        Exercise

    Class of relevant security Product description
    e.g. call option    		 Exercising/ exercised against Number of securities Exercise price per unit

    (d)        Other dealings (including subscribing for new securities)

    Class of relevant security Nature of dealing
    e.g. subscription, conversion    		 Details Price per unit (if applicable)
    NONE      

    4.        OTHER INFORMATION

    (a)        Indemnity and other dealing arrangements

    Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:
    Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state “none”

    NONE

    (b)        Agreements, arrangements or understandings relating to options or derivatives

    Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to:
    (i)   the voting rights of any relevant securities under any option; or
    (ii)   the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:
    If there are no such agreements, arrangements or understandings, state “none”

    NONE

    (c)        Attachments

    Is a Supplemental Form 8 (Open Positions) attached? NO
    Date of disclosure: 08 APRIL 2025
    Contact name: MARK ELLIOTT
    Telephone number: 01253 376539

    Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

    The Panel’s Market Surveillance Unit is available for consultation in relation to the Code’s disclosure requirements on +44 (0)20 7638 0129.

    The Code can be viewed on the Panel’s website at www.thetakeoverpanel.org.uk.

    The MIL Network –

  • MIL-OSI: Zero Hash Further Enhances its Leading Position as the Crypto-as-a-service provider for Brokerage Firms

    Source: GlobeNewswire (MIL-OSI)

    NEW YORK, April 07, 2025 (GLOBE NEWSWIRE) — Zero Hash, the leading infrastructure for stablecoins and crypto, today announced that it is one of the first in the industry to complete an independent assessment of its infrastructure against the U.S. Securities and Exchange Commission’s Regulation Systems Compliance and Integrity (“Reg SCI”) requirements. While not subject to Reg SCI, Zero Hash has taken the effort to voluntarily confirm that its systems exceed the most stringent capacity, integrity, security, resiliency, and infrastructure standards in financial markets.

    This milestone reinforces Zero Hash’s unrivaled position as the go-to infrastructure provider for the explosion of digital assets adoption among broker-dealers, asset managers, and financial institutions globally. Zero Hash powers many of the leading brokerage and neo-banks including Interactive Brokers, tastytrade, Current and MoneyLion. The rigorous third-party assessment was conducted by Schellman Compliance LLC, which verified that Zero Hash exceeds Reg SCI’s high standards and maintains industry-leading, robust, secure, and resilient systems.

    “Although Zero Hash does not deal in securities, many of our customers are overseen by the SEC. This assessment further demonstrates what sets us apart – our unwavering commitment to providing the most comprehensive, scalable, and secure solutions for our customers and end users,” said Scott Minneman, Chief Information Security Officer at Zero Hash. “We are powering the future of finance. Having Reg SCI verification further secures our position as the partner of choice for the world’s largest financial institutions embracing digital assets.”

    About Zero Hash
    Zero Hash is the leading crypto and stablecoin infrastructure provider that seamlessly connects fiat, crypto, and stablecoins in one platform, enabling a better way to move and transfer money and value globally.

    Through its embeddable infrastructure, start-ups, enterprises, and Fortune 500 companies build a diverse range of use cases, including cross-border payments, commerce, trading, remittance, payroll, tokenization, wallets, and on/off-ramps.

    Zero Hash Holdings is backed by investors, including Point72 Ventures, Bain Capital Ventures, and NYCA.

    Zero Hash Trust Company LLC will be established in North Carolina and hold a non-depository trust charter issued by the North Carolina Commissioner of Banks.

    Zero Hash LLC is a FinCen-registered Money Service Business and a regulated Money Transmitter that can operate in 51 U.S. jurisdictions. Zero Hash LLC and Zero Hash Liquidity Services LLC are licensed to engage in virtual currency business activity by the New York State Department of Financial Services. In Canada, Zero Hash LLC is registered as a Money Service Business with FINTRAC.

    Zero Hash Australia Pty Ltd. is registered with AUSTRAC as a Digital Currency Exchange Provider, with DCE registered provider number DCE100804170-001. Zero Hash Australia Pty Ltd. is registered on the New Zealand register of financial service providers, with Financial Service Provider (FSP) number FSP1004503. Zero Hash Europe B.V. is registered as a Virtual Asset Services Provider (VASP) by the Dutch Central Bank (Relation number: R193684). Zero Hash Europe Sp. Zoo is registered as a VASP by the Tax Administration Chamber of Poland in Katowice (Registration number RDWW – 1212).

    Media Contacts
    Zero Hash
    Shaun O’Keeffe
    (855) 744-7333
    media@zerohash.com 

    The MIL Network –

  • MIL-OSI: Form 8.3 – [ADVANCED MEDICAL SOLUTIONS GROUP PLC – 04 04 2025] – (CGWL)

    Source: GlobeNewswire (MIL-OSI)

    FORM 8.3

    PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY
    A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE
    Rule 8.3 of the Takeover Code (the “Code”)

    1.        KEY INFORMATION

    (a)   Full name of discloser: CANACCORD GENUITY WEALTH LIMITED (for Discretionary clients)
    (b)   Owner or controller of interests and short positions disclosed, if different from 1(a):
            The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.    		 N/A
    (c)   Name of offeror/offeree in relation to whose relevant securities this form relates:
            Use a separate form for each offeror/offeree    		 ADVANCED MEDICAL SOLUTIONS GROUP PLC
    (d)   If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree: N/A
    (e)   Date position held/dealing undertaken:
            For an opening position disclosure, state the latest practicable date prior to the disclosure    		 04 APRIL 2025
    (f)   In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?
            If it is a cash offer or possible cash offer, state “N/A”    		 N/A

    2.        POSITIONS OF THE PERSON MAKING THE DISCLOSURE

    If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

    (a)      Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

    Class of relevant security: 5p ORDINARY
      Interests Short positions
    Number % Number %
    (1)   Relevant securities owned and/or controlled: 11,896,771 5.4566    
    (2)   Cash-settled derivatives:        
    (3)   Stock-settled derivatives (including options) and agreements to purchase/sell:        
    TOTAL: 11,896,771 5.4566    

    All interests and all short positions should be disclosed.

    Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

    (b)      Rights to subscribe for new securities (including directors’ and other employee options)

    Class of relevant security in relation to which subscription right exists:  
    Details, including nature of the rights concerned and relevant percentages:  

    3.        DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

    Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

    The currency of all prices and other monetary amounts should be stated.

    (a)        Purchases and sales

    Class of relevant security Purchase/sale Number of securities Price per unit
    5p ORDINARY PURCHASE 6,040 208.9235p

    (b)        Cash-settled derivative transactions

    Class of relevant security Product description
    e.g. CFD    		 Nature of dealing
    e.g. opening/closing a long/short position, increasing/reducing a long/short position    		 Number of reference securities Price per unit
    NONE        

    (c)        Stock-settled derivative transactions (including options)

    (i)        Writing, selling, purchasing or varying

    Class of relevant security Product description e.g. call option Writing, purchasing, selling, varying etc. Number of securities to which option relates Exercise price per unit Type
    e.g. American, European etc.    		 Expiry date Option money paid/ received per unit
    NONE              

    (ii)        Exercise

    Class of relevant security Product description
    e.g. call option    		 Exercising/ exercised against Number of securities Exercise price per unit

    (d)        Other dealings (including subscribing for new securities)

    Class of relevant security Nature of dealing
    e.g. subscription, conversion    		 Details Price per unit (if applicable)
    NONE      

    4.        OTHER INFORMATION

    (a)        Indemnity and other dealing arrangements

    Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:
    Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state “none”

    NONE

    (b)        Agreements, arrangements or understandings relating to options or derivatives

    Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to:
    (i)   the voting rights of any relevant securities under any option; or
    (ii)   the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:
    If there are no such agreements, arrangements or understandings, state “none”

    NONE

    (c)        Attachments

    Is a Supplemental Form 8 (Open Positions) attached? NO
    Date of disclosure: 07 APRIL 2025
    Contact name: MARK ELLIOTT
    Telephone number: 01253 376539

    Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

    The Panel’s Market Surveillance Unit is available for consultation in relation to the Code’s disclosure requirements on +44 (0)20 7638 0129.

    The Code can be viewed on the Panel’s website at www.thetakeoverpanel.org.uk.

    The MIL Network –

  • MIL-OSI Asia-Pac: Leaders of Indian Origin Tamil from Sri Lanka meet PM

    Source: Government of India

    Posted On: 05 APR 2025 9:53PM by PIB Delhi

    The leaders of Indian Origin Tamil (IOT) from Sri Lanka met the Prime Minister Shri Narendra Modi today in Colombo. Shri Modi announced that India will support construction  of 10,000 houses, healthcare facilities, the sacred site Seetha Eliya temple and other community development projects for IOTs in cooperation with the Government of Sri Lanka.

    In separate posts on X, he said:

    “The meeting with leaders of Indian Origin Tamil (IOT) was fruitful. The community constitutes a living bridge between the two countries for over 200 years. India will support construction  of 10,000 houses, healthcare facilities, the sacred site Seetha Eliya temple and other community development projects for IOTs in cooperation with the Government of Sri Lanka.”

    “இந்தியாவை பூர்வீகமாக கொண்ட தமிழ் மக்களுடன் சுமூகமான சந்திப்பு இடம்பெற்றிருந்தது. இச்சமூகத்தினர் 200 ஆண்டுகளுக்கும் மேலாக இரு நாடுகளுக்குமான ஒரு வாழும் உறவுப் பாலமாக திகழ்கின்றனர். இலங்கை அரசாங்கத்துடனான ஒத்துழைப்புடன் இந்தியாவை பூர்வீகமாக கொண்ட தமிழ் மக்களுக்காக 10000 வீடுகள், சுகாதார வசதிகள், புனித சீதை அம்மன் ஆலயம் ஆகியவற்றின் நிர்மாணம் மற்றும் ஏனைய சமூக அபிவிருத்தி திட்டங்களுக்காக இந்தியா ஆதரவு வழங்கும்.”

     

     

     

    ***

    MJPS/SR

    (Release ID: 2119404) Visitor Counter : 51

    MIL OSI Asia Pacific News –

  • MIL-OSI: Form 8.3 – [ADVANCED MEDICAL SOLUTIONS GROUP PLC – 03 04 2025] – (CGWL)

    Source: GlobeNewswire (MIL-OSI)

    FORM 8.3

    PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY
    A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE
    Rule 8.3 of the Takeover Code (the “Code”)

    1.        KEY INFORMATION

    (a)   Full name of discloser: CANACCORD GENUITY WEALTH LIMITED (for Discretionary clients)
    (b)   Owner or controller of interests and short positions disclosed, if different from 1(a):
            The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.    		 N/A
    (c)   Name of offeror/offeree in relation to whose relevant securities this form relates:
            Use a separate form for each offeror/offeree    		 ADVANCED MEDICAL SOLUTIONS GROUP PLC
    (d)   If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree: N/A
    (e)   Date position held/dealing undertaken:
            For an opening position disclosure, state the latest practicable date prior to the disclosure    		 03 APRIL 2025
    (f)   In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?
            If it is a cash offer or possible cash offer, state “N/A”    		 N/A

    2.        POSITIONS OF THE PERSON MAKING THE DISCLOSURE

    If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

    (a)      Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

    Class of relevant security: 5p ORDINARY
      Interests Short positions
    Number % Number %
    (1)   Relevant securities owned and/or controlled: 11,890,731 5.4538    
    (2)   Cash-settled derivatives:        
    (3)   Stock-settled derivatives (including options) and agreements to purchase/sell:        
    TOTAL: 11,890,731 5.4538    

    All interests and all short positions should be disclosed.

    Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

    (b)      Rights to subscribe for new securities (including directors’ and other employee options)

    Class of relevant security in relation to which subscription right exists:  
    Details, including nature of the rights concerned and relevant percentages:  

    3.        DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

    Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

    The currency of all prices and other monetary amounts should be stated.

    (a)        Purchases and sales

    Class of relevant security Purchase/sale Number of securities Price per unit
    5p ORDINARY SALE 1,900 221.25p
    5p ORDINARY SALE 8,600 223p
    5p ORDINARY PURCHASE 4,975 219p
    5p ORDINARY PURCHASE 8,600 223.5p

    (b)        Cash-settled derivative transactions

    Class of relevant security Product description
    e.g. CFD    		 Nature of dealing
    e.g. opening/closing a long/short position, increasing/reducing a long/short position    		 Number of reference securities Price per unit
    NONE        

    (c)        Stock-settled derivative transactions (including options)

    (i)        Writing, selling, purchasing or varying

    Class of relevant security Product description e.g. call option Writing, purchasing, selling, varying etc. Number of securities to which option relates Exercise price per unit Type
    e.g. American, European etc.    		 Expiry date Option money paid/ received per unit
    NONE              

    (ii)        Exercise

    Class of relevant security Product description
    e.g. call option    		 Exercising/ exercised against Number of securities Exercise price per unit

    (d)        Other dealings (including subscribing for new securities)

    Class of relevant security Nature of dealing
    e.g. subscription, conversion    		 Details Price per unit (if applicable)
    NONE      

    4.        OTHER INFORMATION

    (a)        Indemnity and other dealing arrangements

    Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:
    Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state “none”

    NONE

    (b)        Agreements, arrangements or understandings relating to options or derivatives

    Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to:
    (i)   the voting rights of any relevant securities under any option; or
    (ii)   the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:
    If there are no such agreements, arrangements or understandings, state “none”

    NONE

    (c)        Attachments

    Is a Supplemental Form 8 (Open Positions) attached? NO
    Date of disclosure: 04 APRIL 2025
    Contact name: MARK ELLIOTT
    Telephone number: 01253 376539

    Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

    The Panel’s Market Surveillance Unit is available for consultation in relation to the Code’s disclosure requirements on +44 (0)20 7638 0129.

    The Code can be viewed on the Panel’s website at www.thetakeoverpanel.org.uk.

    The MIL Network –

  • MIL-OSI: ARB IOT Group Limited Introduces AI Drone Technology to Revolutionise Plantation Management

    Source: GlobeNewswire (MIL-OSI)

    Kuala Lumpur, Malaysia, April 03, 2025 (GLOBE NEWSWIRE) — ARB IOT Group Limited (“ARB IOT” or the “Company”) (NASDAQ: ARBB) has introduced its advanced AI-powered plantation mapping system which is seamlessly integrated with drone technology (“Smart AI Drone”), designed to revolutionise plantation management. This innovative technology aims to optimize the plantation mapping processes, enhance efficiency and crop yields, and boost sustainability and productivity in modern agriculture.

    Equipped with advanced imaging, artificial intelligence, and real-time data analytics, the Smart AI Drone offers a comprehensive solution for farmers and plantation owners. The new service provides capabilities such as precision mapping, crop health monitoring, pest detection, and automated spraying, ensuring optimal growth conditions and reducing resource wastage.

    “Our mission is to empower farmers with smart solutions that increase yield while promoting sustainable farming practices,” said Dato’ Sri Liew Kok Leong, CEO of ARB IOT. “With our drone technology, we are enabling plantations to make data-driven decisions that optimise resources and improve overall productivity.”

    By leveraging high-resolution aerial imaging and AI-powered analytics, the service can detect early signs of disease, nutrient deficiencies, and irrigation needs. This targeted approach minimizes environmental impact by reducing the excessive use of pesticides, fertilizers, and water.

    The Smart AI Drone is tailored for commercial plantations and farms across the country to meet the diverse needs of agricultural businesses, ensuring accessibility and affordability.

    About ARB IOT Group Limited

    ARB IOT Group Limited is a provider of complete solutions to clients for the integration of Internet of Things (IoT) systems and devices from designing to project deployment. We offer a wide range of IoT systems as well as provide customers a substantial range of services such as system integration and system support service. We deliver holistic solutions with full turnkey deployment from designing, installation, testing, pre-commissioning, and commissioning of various IoT systems and devices as well as integration of automated systems, including installation of wire and wireless and mechatronic works.

    Safe Harbor Statement

    This press release contains “forward-looking statements” that involve substantial risks and uncertainties. All statements other than statements of historical facts contained in this press release, such as statements regarding our estimated future results of operations and financial position, our strategy and plans, and our objectives or goals, are forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended and Section 21E of the Securities Exchange Act of 1934, as amended. We have attempted to identify forward-looking statements by terminology including “anticipates,” “believes,” “can,” “continue,” “could,” “estimates,” “expects,” “intends,” “may,” “plans,” “potential,” “predicts,” “should,” or “will” or the negative of these terms or other comparable terminology. Our actual results may differ materially or perhaps significantly from those discussed herein, or implied by, these forward-looking statements. There are a significant number of factors that could cause actual results to differ materially from statements made in this press release, including, but not limited to, those that we discussed or referred to in the Company’s disclosure documents filed with the U.S. Securities and Exchange Commission (the “SEC”) available on the SEC’s website at www.sec.gov, including the Company’s Annual Report on Form 20-F as well as in our other reports filed or furnished from time to time with the SEC. The forward-looking statements included in this press release are made as of the date of this press release and the Company undertakes no obligation to publicly update or revise any forward looking statements, other than as required by applicable law.

    For further information, please contact:
    ARB IOT Group Limited
    Investor Relations Department
    Email: contact@arbiotgroup.com

    The MIL Network –

  • MIL-OSI: Form 8.3 – [ADVANCED MEDICAL SOLUTIONS GROUP PLC – 02 04 2025] – (CGWL)

    Source: GlobeNewswire (MIL-OSI)

    FORM 8.3

    PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY
    A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE
    Rule 8.3 of the Takeover Code (the “Code”)

    1.        KEY INFORMATION

    (a)   Full name of discloser: CANACCORD GENUITY WEALTH LIMITED (for Discretionary clients)
    (b)   Owner or controller of interests and short positions disclosed, if different from 1(a):
            The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.    		 N/A
    (c)   Name of offeror/offeree in relation to whose relevant securities this form relates:
            Use a separate form for each offeror/offeree    		 ADVANCED MEDICAL SOLUTIONS GROUP PLC
    (d)   If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree: N/A
    (e)   Date position held/dealing undertaken:
            For an opening position disclosure, state the latest practicable date prior to the disclosure    		 02 APRIL 2025
    (f)   In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?
            If it is a cash offer or possible cash offer, state “N/A”    		 N/A

    2.        POSITIONS OF THE PERSON MAKING THE DISCLOSURE

    If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

    (a)      Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

    Class of relevant security: 5p ORDINARY
      Interests Short positions
    Number % Number %
    (1)   Relevant securities owned and/or controlled: 11,887,656 5.4524    
    (2)   Cash-settled derivatives:        
    (3)   Stock-settled derivatives (including options) and agreements to purchase/sell:        
    TOTAL: 11,887,656 5.4524    

    All interests and all short positions should be disclosed.

    Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

    (b)      Rights to subscribe for new securities (including directors’ and other employee options)

    Class of relevant security in relation to which subscription right exists:  
    Details, including nature of the rights concerned and relevant percentages:  

    3.        DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

    Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

    The currency of all prices and other monetary amounts should be stated.

    (a)        Purchases and sales

    Class of relevant security Purchase/sale Number of securities Price per unit
    5p ORDINARY PURCHASE 6,870 220.98p
    5p ORDINARY PURCHASE 5,250 224p
    5p ORDINARY SALE 8,870 221.001p
    5p ORDINARY SALE 1,500 222.75p
    5p ORDINARY SALE 6,600 224p
    5p ORDINARY SALE 7,000 225p
    5p ORDINARY SALE 7,980 226.75p

    (b)        Cash-settled derivative transactions

    Class of relevant security Product description
    e.g. CFD    		 Nature of dealing
    e.g. opening/closing a long/short position, increasing/reducing a long/short position    		 Number of reference securities Price per unit
    NONE        

    (c)        Stock-settled derivative transactions (including options)

    (i)        Writing, selling, purchasing or varying

    Class of relevant security Product description e.g. call option Writing, purchasing, selling, varying etc. Number of securities to which option relates Exercise price per unit Type
    e.g. American, European etc.    		 Expiry date Option money paid/ received per unit
    NONE              

    (ii)        Exercise

    Class of relevant security Product description
    e.g. call option    		 Exercising/ exercised against Number of securities Exercise price per unit

    (d)        Other dealings (including subscribing for new securities)

    Class of relevant security Nature of dealing
    e.g. subscription, conversion    		 Details Price per unit (if applicable)
    NONE      

    4.        OTHER INFORMATION

    (a)        Indemnity and other dealing arrangements

    Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:
    Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state “none”

    NONE

    (b)        Agreements, arrangements or understandings relating to options or derivatives

    Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to:
    (i)   the voting rights of any relevant securities under any option; or
    (ii)   the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:
    If there are no such agreements, arrangements or understandings, state “none”

    NONE

    (c)        Attachments

    Is a Supplemental Form 8 (Open Positions) attached? NO
    Date of disclosure: 03 APRIL 2025
    Contact name: MARK ELLIOTT
    Telephone number: 01253 376539

    Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

    The Panel’s Market Surveillance Unit is available for consultation in relation to the Code’s disclosure requirements on +44 (0)20 7638 0129.

    The Code can be viewed on the Panel’s website at www.thetakeoverpanel.org.uk.

    The MIL Network –

  • MIL-OSI Asia-Pac: NATIONAL MISSION ON INTERDISCIPLINARY-CYBER PHYSICAL SYSTEMS

    Source: Government of India

    Ministry of Science & Technology

    NATIONAL MISSION ON INTERDISCIPLINARY-CYBER PHYSICAL SYSTEMS

    Posted On: 02 APR 2025 5:37PM by PIB Delhi

    The details of the total number of research projects piloted under National Mission on Interdisciplinary Cyber Physical Systems (NM-ICPS), along with the funds allocated and disbursed, year-wise and location-wise are as under:

    S. No.

    TIH Name & Location

    No. of Research Projects

    Funds Allocated

    (In Lakhs)

    Funds Disbursed (in Lakhs)

    (Financial year-wise)

    2020-21

    2021-22

    2022-23

    2023-24

    2024-25

    1

    TIH Foundation For IOT And IOE, IIT Bombay, Powai, Mumbai, Maharashtra – 400076

    88

    3715.37

    –

    –

    317.25

    639.42

    490.82

    2

    IIIT-H Data I-Hub Foundation, IIIT Hyderabad, Gachibowli, Hyderabad, Telangana – 500032

    68

    1272.9

    13.14

    189.41

    82.67

    508.09

    132.09

    3

    I-HUB for Robotics and Autonomous Systems Innovation Foundation, IISc Bengaluru, CV Raman Rd, Bengaluru, Karnataka – 560012

    5

    7667.53

    165.32

    537.08

    1430.74

    2340.64

    3193.75

    4

    IHUB NTIHAC Foundation, IIT Kanpur, Kalyanpur, Kanpur, Uttar Pradesh – 208016

    50

    1300.13

    –

    139.65

    211.62

    346.39

    301.92

    5

    IHUB Drishti Foundation, IIT Jodhpur, NH 62, Karwar, Jodhpur, Rajasthan – 342030

    50

    2369.63

    174

    441.87

    935.29

    818.47

    –

    6

    Divyasampark IHUB Roorkee for Devices Materials and Technology Foundation, IIT Roorkee, Roorkee, Uttarakhand – 247667

    88

    2968.99

    285.20

    468.20

    444.40

    1442.79

    264.40

    7

    IIT Patna Vishlesan I-hub Foundation, IIT Patna, Bihta, Patna, Bihar – 801106

    7

    199.95

    –

    –

    34.33

    18.33

    13.08

    8

    IIT Madras Pravartak Technologies Foundation, IIT Madras, Sardar Patel Rd, Chennai, Tamil Nadu – 600036

    31

    2508.48

    –

    1326.73

    160.44

    930.20

    91.11

    9

    NMICPS Technology Innovation Hub on Autonomous Navigation Foundation (TiHAN), IIT Hyderabad, Kandi, Sangareddy, Telangana – 502284

    153

    3158.65

    –

    1008.43

    1242.39

    395.02

    186.58

    10

    I-DAPT-HUB Foundation, IIT (BHU) Varanasi, Banaras Hindu University, Varanasi, Uttar Pradesh – 221005

    25

    488.91

    –

    44.55

    189.59

    168.40

    62.53

    11

    IIT Guwahati Technology Innovation and Development Foundation, IIT Guwahati, Amingaon, Guwahati, Assam – 781039

    151

    4727.57

    –

    315

    533.87

    3641.20

    237.50

    12

    IIT MandiIHub and HCI Foundation, IIT Mandi, Kamand, Mandi, Himachal Pradesh – 175075

    24

    1746.34

    –

    –

    328.03

    354

    588.48

    13

    I-Hub Foundation for Cobotics (IHFC), IIT Delhi, Hauz Khas, New Delhi – 110016

    49

    4339

    32.35

    1007.30

    586.47

    397.96

    176.42

    14

    IIT Palakkad Technology Ihub Foundation, IIT Palakkad, Pudussery, Palakkad, Kerala – 678623

    63

    2498.58

    –

    281.25

    530.52

    326.35

    574.96

    15

    IIT Ropar Technology and Innovation Foundation, IIT Ropar, Rupnagar, Punjab – 140001

    87

    4831.13

    4

    545.14

    703.20

    861.91

    676.02

    16

    Technology Innovation in Exploration & Mining Foundation, IIT (ISM) Dhanbad, Sardar Patel Nagar, Dhanbad, Jharkhand – 826004

    62

    1933

    –

    94.66

    79.84

    705.55

    476.51

    17

    IIITB Comet Foundation, IIIT Bangalore, Electronic City, Bangalore, Karnataka – 560100

    17

    10872.51

    –

    –

    1156.70

    2370.19

    2386.34

    18

    BITS BioCYTiH Foundation, BITS Pilani, VidyaVihar, Pilani, Rajasthan – 333031

    43

    1942.07

    –

    20.71

    160.77

    488.22

    429.82

    19

    IDEAS – Institute of Data Engineering, Analytics and Science Foundation, ISI Kolkata, 203, Barrackpore Trunk Road, Kolkata, West Bengal – 700108

    20

    912

    –

    0

    222

    266.80

    48.50

    20

    IITI Drishti CPS Foundation, IIT Indore, Khandwa Road, Simrol, Indore, Madhya Pradesh – 453552

    82

    696.40

    –

    7.68

    173.06

    229.86

    88.33

    21

    AI4ICPS I-Hub Foundation, IIT Kharagpur, Kharagpur, West Bengal – 721302

    63

    1474.45

    –

    –

    –

    1474.45

    –

    22

    IHUB Anubhuti-IIITD Foundation, IIIT Delhi, Okhla Industrial Estate, New Delhi – 110020

    35

    1482.26

    –

    54.72

    228.91

    241.87

    258.54

    23

    I-Hub Quantum Technology Foundation, IISER Pune, Dr.HomiBhabha Road, Pashan, Pune, Maharashtra – 411008

    27

    8619.37

    –

    –

    949.72

    1388.11

    86.51

    24

    IIT TirupatiNavavishkar I-Hub Foundation, IIT Tirupati, Yerpedu, Chittoor, Andhra Pradesh – 517619

    27

    1290.93

    –

    –

    –

    401.18

    714.81

    25

    IIT Bhilai Innovation and Technology Foundation, IIT Bhilai, Kutelabhata, Bhilai, Chhattisgarh – 490020

    96

    5238.62

    –

    38.58

    153.72

    2242.92

    –

    Subtotal

    1411

    78254.77

    674.01

    6520.96

    10855.53

    22998.32

    11479.02

    Total

    52527.84

    The number of technology products developed and jobs created by supported projects under NM-ICPS, location-wise are as under:

    S. No.

    TIH Name & Location

    No. of Technology Products Developed

    No. of Jobs created

    1

    TIH Foundation For IOT And IOE, IIT Bombay, Powai, Mumbai, Maharashtra – 400076

    17

    89

    2

    IIIT-H Data I-Hub Foundation, IIIT Hyderabad, Gachibowli, Hyderabad, Telangana – 500032

    38

    152

    3

    I-HUB for Robotics and Autonomous Systems Innovation Foundation, IISc Bengaluru, CV Raman Rd, Bengaluru, Karnataka – 560012

    54

    –

    4

    IHUB NTIHAC Foundation, IIT Kanpur, Kalyanpur, Kanpur, Uttar Pradesh – 208016

    62

    126

    5

    IHUB Drishti Foundation, IIT Jodhpur, NH 62, Karwar, Jodhpur, Rajasthan – 342030

    –

    1238

    6

    Divyasampark IHUB Roorkee for Devices Materials and Technology Foundation, IIT Roorkee, Roorkee, Uttarakhand – 247667

    3

    16

    7

    IIT Patna Vishlesan I-hub Foundation, IIT Patna, Bihta, Patna, Bihar – 801106

    –

    –

    8

    IIT Madras Pravartak Technologies Foundation, IIT Madras, Sardar Patel Rd, Chennai, Tamil Nadu – 600036

    31

    68

    9

    NMICPS Technology Innovation Hub on Autonomous Navigation Foundation (TiHAN), IIT Hyderabad, Kandi, Sangareddy, Telangana – 502284

    198

    781

    10

    I-DAPT-HUB Foundation, IIT (BHU) Varanasi, Banaras Hindu University, Varanasi, Uttar Pradesh – 221005

    31

    61

    11

    IIT Guwahati Technology Innovation and Development Foundation, IIT Guwahati, Amingaon, Guwahati, Assam – 781039

    78

    138

    12

    IIT MandiIHub and HCI Foundation, IIT Mandi, Kamand, Mandi, Himachal Pradesh – 175075

    7

    22

    13

    I-Hub Foundation for Cobotics (IHFC), IIT Delhi, HauzKhas, New Delhi – 110016

    40

    85

    14

    IIT Palakkad Technology Ihub Foundation, IIT Palakkad, Pudussery, Palakkad, Kerala – 678623

    11

    51

    15

    IIT Ropar Technology and Innovation Foundation, IIT Ropar, Rupnagar, Punjab – 140001

    72

    167

    16

    Technology Innovation in Exploration & Mining Foundation, IIT (ISM) Dhanbad, Sardar Patel Nagar, Dhanbad, Jharkhand – 826004

    34

    818

    17

    IIITB Comet Foundation, IIIT Bangalore, Electronic City, Bangalore, Karnataka – 560100

    15

    338

    18

    BITS BioCYTiH Foundation, BITS Pilani, VidyaVihar, Pilani, Rajasthan – 333031

    5

    6

    19

    IDEAS – Institute of Data Engineering, Analytics and Science Foundation, ISI Kolkata, 203, Barrackpore Trunk Road, Kolkata, West Bengal – 700108

    28

    54

    20

    IITI Drishti CPS Foundation, IIT Indore, Khandwa Road, Simrol, Indore, Madhya Pradesh – 453552

    83

    170

    21

    IHUB Anubhuti-IIITD Foundation, IIIT Delhi, Okhla Industrial Estate, New Delhi – 110020

    66

    107

    22

    AI4ICPS I-Hub Foundation, IIT Kharagpur, Kharagpur, West Bengal – 721302

    17

    146

    23

    I-Hub Quantum Technology Foundation, IISER Pune, Dr.HomiBhabha Road, Pashan, Pune, Maharashtra – 411008

    12

    29

    24

    IIT TirupatiNavavishkar I-Hub Foundation, IIT Tirupati, Yerpedu, Chittoor, Andhra Pradesh – 517619

    –

    –

    25

    IIT Bhilai Innovation and Technology Foundation, IIT Bhilai, Kutelabhata, Bhilai, Chhattisgarh – 490020

    71

    295

    Total

    973

    4957

     

    A list of TIHs approved and established under NM-ICPS (State-wise) along with the total funds allocated and disbursed (year-wise) till date is as under:

    TIH Name & Host Institution

    State/UT

    Sanctioned Year

    Funds Allocated (₹ Cr)

    Funds Disbursed (₹ Cr)

    TIH Foundation For IOT And IOE, IIT Bombay

    Maharashtra

    2020

    170.00

    97.41

    Project ‘BharatGen’ on LLM

    2024

    235.18

    89.66

    IIIT-H Data I-Hub Foundation, IIIT Hyderabad

    Hyderabad

    2020

    110.00

    58.77

    I-HUB for Robotics and Autonomous Systems Innovation Foundation, IISc Bangalore

    Karnataka

    2020

    170.00

    113.25

    IHUB NTIHAC Foundation, IIT Kanpur

    Uttar Pradesh

    2020

    170.00

    143.19

    IHUB Drishti Foundation, IIT Jodhpur

    Rajasthan

    2020

    115.00

    54.95

    Divyasampark IHUB Roorkee for Devices Materials and Technology Foundation, IIT Roorkee

    Uttarakhand

    2020

    135.00

    111.70

    IIT Patna Vishlesan I-hub Foundation, IIT Patna

    Bihar

    2020

    110.00

    22.25

    IIT Madras Pravartak Technologies Foundation, IIT Madras

    Tamil Nadu

    2020

    170.00

    156.18

    NMICPS Technology Innovation Hub on Autonomous Navigation Foundation (TiHAN), IIT Hyderabad

    Hyderabad

    2020

    135.00

    127.43

    I-DAPT-HUB Foundation, IIT (BHU) Varanasi

    Uttar Pradesh

    2020

    110.00

    23.37

    IIT Guwahati Technology Innovation and Development Foundation, IIT Guwahati

    Assam

    2020

    135.00

    92.76

    IIT MandiIHub and HCI Foundation, IIT Mandi

    Himachal Pradesh

    2020

    110.00

    58.25

    I-Hub Foundation for Cobotics (IHFC), IIT Delhi

    Delhi

    2020

    170.00

    85.92

    IIT Palakkad Technology Ihub Foundation, IIT Palakkad

    Kerala

    2020

    100.00

    47.08

    IIT Ropar Technology and Innovation Foundation, IIT Ropar

    Punjab

    2020

    110.00

    79.12

    Technology Innovation in Exploration & Mining Foundation, IIT Dhanbad

    Jharkhand

    2020

    110.00

    63.20

    IIITB Comet Foundation, IIIT Bangalore

    Karnataka

    2020

    150.00

    69.59

    BITS BioCYTiH Foundation, BITS Pilani

    Rajasthan

    2020

    125.00

    59.25

    IDEAS – Institute of Data Engineering, Analytics and Science Foundation, ISI Kolkata

    Kolkata

    2020

    100.00

    12.19

    AI4ICPS I-Hub Foundation, IIT Kharagpur

    Kolkata

    2020

    170.00

    24.45

    IITI Drishti CPS Foundation, IIT Indore

    Madhya Pradesh

    2020

    100.00

    47.19

    IHUB Anubhuti-IIITD Foundation, IIIT Delhi

    Delhi

    2020

    100.00

    36.59

    I-Hub Quantum Technology Foundation, IISER Pune

    Maharashtra

    2020

    170.00

    88.13

    IIT TirupatiNavavishkar I-Hub Foundation, IIT Tirupati

    Andhra Pradesh

    2020

    100.00

    39.75

    IIT Bhilai Innovation and Technology Foundation, IIT Bhilai

    Chhattisgarh

    2020

    55.00

    50.80

    Total

    3435.18

    1852.43

    The details of the number of Centre of Excellence (CoEs) established under NM-ICPS, year-wise and State-wise is as under:

    S. No.

    Name of State/UT

    No. of CoEs Established (year-wise)

    1

    Uttar Pradesh

    2 (2022, 2025)

    2

    Goa

    3 (2023, 2025)

    3

    Tamil Nadu

    2 (2024, 2025)

    4

    Himachal Pradesh

    2 (2024)

    5

    Haryana

    1 (2022)

    6

    Delhi

    3 (2023)

    7

    Jharkhand

    10 (2022, 2023, 2024, 2025)

    8

    Karnataka

    4 (2023, 2024, 2025)

    9

    Nagaland

    1 (2025)

    10

    Manipur

    1 (2025)

    11

    Mizoram

    1 (2025)

    12

    Maharashtra

    1 (2025)

    13

    West Bengal

    1 (2025)

    14

    Madhya Pradesh

    1 (2023)

    15

    Rajasthan

    2 (2024, 2025)

    16

    Andhra Pradesh

    5 (2025)

    17

    Telangana

    2 (2025)

    18

    Kerala

    2 (2023, 2025)

    19

    Punjab

    12 (2022, 2023, 2024, 2025)

    20

    Uttarakhand

    1 (2024)

    21

    Ladakh

    1 (2024)

    22

    Sikkim

    1 (2024)

    23

    Assam

    5 (2022, 2023, 2024)

    Total

    64

     

    The total number of Government and Industry Research and Development (R&D) labs participating under NM-ICPS, year-wise and State-wise are as under:

    S. No.

    TIH Name

    State

    Total number of Government and Industry Research and Development (R&D) labs (year-wise)

    1

    IIIT-H Data I-Hub Foundation

    Telangana

    44 (2021, 2022, 2023, 2024, 2025)

    2

    NMICPS Technology Innovation Hub on Autonomous Navigation Foundation (TiHAN)

    3

    I-HUB for Robotics and Autonomous Systems Innovation Foundation

    Karnataka

    5 (2021, 2023, 2024, 2025)

    4

    I-DAPT-HUB Foundation

    Uttar Pradesh

    5 (2020, 2021, 2022, 2023)

    5

    IHUB Drishti Foundation

    Rajasthan

    6 (2024, 2025)

    6

    BITS BioCYTiH Foundation

    7

    IIT Madras Pravartak Technologies Foundation

    Tamil Nadu

    5 (2021, 2022)

    8

    IIT Guwahati Technology Innovation and Development Foundation

    Assam

    11 (2023, 2024)

    9

    IIT MandiIHub and HCI Foundation

    Himachal Pradesh

    5 (2022, 2023)

    10

    I-Hub Foundation for Cobotics (IHFC)

    Delhi

    55 (2020, 2022, 2023, 2024, 2025)

    11

    IHUB Anubhuti-IIITD Foundation

    12

    IIT Palakkad Technology Ihub Foundation

    Kerala

    4 (2023, 2024, 2025)

    13

    IIT Ropar Technology and Innovation Foundation

    Punjab

    6 (2021, 2022, 2023, 2024)

    14

    Technology Innovation in Exploration & Mining Foundation

    Jharkhand

    4 (2022, 2023, 2024)

    15

    IIT Kharagpur AI4ICPS I-Hub Foundation

    West Bengal

    6 (2023, 2024, 2025)

    16

    IITI Drishti CPS Foundation

    Madhya Pradesh

    6 (2021, 2022, 2024)

    17

    IIT TirupatiNavavishkar I-Hub Foundation

    Andhra Pradesh

    4 (2023, 2024)

    18

    IIT Bhilai Innovation and Technology Foundation

    Chhattisgarh

    2 (2022, 2024)

    Total

    168

     

    This information was given by Dr. Jitendra Singh, Minister of State (Independent Charge) of the Ministry of Science & Technology and Earth Sciences, in a written reply in the Lok Sabha today.

    ***

    NKR/PSM

    (Release ID: 2117875)

    MIL OSI Asia Pacific News –

  • MIL-OSI Asia-Pac: Make in India and the Capital Goods Revolution

    Source: Government of India

    Make in India and the Capital Goods Revolution

    Catalyzing Domestic Production and Technological Innovation

    Posted On: 02 APR 2025 6:52PM by PIB Delhi

    Introduction

    According to the Ministry of Heavy Industries, heavy engineering and machine tools sector comprises of capital goods industry. India’s capital goods sector is experiencing significant attention due to its critical role in driving industrial growth and economic development. This sector encompasses industries such as electrical equipment, machinery, and construction, which are essential for the country’s infrastructure development. According to the Indian Electrical and Electronics Manufacturers’ Association (IEEMA), the electrical equipment industry witnessed consistent double-digit growth in power equipment, particularly transmission equipment and transformers, driven by domestic demand and international market expansion.

    India is the third-largest market for construction equipment. Government initiatives have been instrumental in bolstering the capital goods sector. The Ministry of Heavy Industries has launched several policies to boost domestic production and reduce reliance on imports. These initiatives are part of the broader Make in India campaign (launched in 2014), which seeks to increase the manufacturing sector’s contribution to GDP, generate employment, and improve technological capabilities. The capital goods sector is crucial to India’s economic strategy, supporting large-scale manufacturing and infrastructure projects. With rapid urbanization, extensive infrastructure development, and strong government support, the sector is poised to drive sustainable industrial growth and elevate India’s position in the global market.

     

    Overview of the Heavy Industries and Engineering Sector

    As per the present estimates, the Capital Goods industry contributes about 1.9% of GDP.  The Heavy Engineering and Machine Tool sector (capital goods industry) consists of the following major sub-sectors: Dies, Moulds and Press Tools; Plastic Machinery; Earthmoving and Mining Machinery; Metallurgical Machinery; Textile Machinery; Process Plant Equipment; Printing Machinery; and Food Processing Machinery. Due to catalytic effect of Ministry of Heavy Industries intervention, the production of capital goods sector has increased from Rs 2,29,533 crore in 2014-15 to Rs.4,29,001 crore in 2023-24. Production (in crores) by the sub-sectors of capital goods industry since 2019-20 are presented in the table below:

     

    Exports (in crores) by the sub-sectors of capital goods industry since 2019-20 are presented in the table below:

     

     

    The policy environment for the capital goods sector includes:

    • No industrial license is required for the sector.
    • FDI up to 100% permitted on automatic route (through RBI) except from the countries having land borders with India.
    • Quantum of payment for technology transfer, design and drawing, royalty, etc. to the foreign collaborator is not restricted.
    • There is no restriction on imports and exports.

    The Union Budget 2025-26 proposes to add 35 additional capital goods for EV battery manufacturing, and 28 additional capital goods for mobile phone battery manufacturing to the list of exempted capital goods. This will boost domestic manufacture of lithium-ion battery, both for mobile phones and electric vehicles.

     

    National Capital Goods Policy (2016)

    The National Capital Goods Policy, formulated by the Ministry of Heavy Industries & Public Enterprises, is a comprehensive framework aims at boosting the capital goods sector in India. policy envisions increasing the sector’s contribution to manufacturing activity from 12% (2016) to 20% by 2025. It seeks to make India one of the top capital goods producing nations, aiming to more than double production and increase exports to at least 40% of the total production. Furthermore, the policy aims to enhance the technology depth within the sector, moving from basic and intermediate levels to advanced levels.

    The major salient features of the policy are:

    1. To increase budgetary allocation and scope of the Scheme on Enhancement of Competitiveness in the Capital Goods Sector adding components i.e. skills, capacity building, advanced manufacturing and cluster development.
    2. To launch a Technology Development Fund under PPP model to fund technology acquisition/ transfer, purchase of IPRs/ designs and drawings/ commercialization.
    3. To set up regional State-of-the-Art Greenfield Centre of Excellence for skill development.
    4. To modernize existing CG manufacturing units, especially SMEs by replacing with the modern, computer controlled and energy efficient machineries across capital goods sub-sectors.
    5. To upgrade/ develop, testing and certification infrastructure.

     

    The National Capital Goods Policy, 2016, inter alia, recommended increasing the budgetary allocation and scope of the Scheme on Enhancement of Competitiveness of Capital Goods which included setting up of Centers of Excellence, Common Engineering Facility Centers, Integrated Industrial Infrastructure Park and Technology Acquisition Fund Programme. These recommendations were incorporated in the Phase II of the scheme.

     

    Scheme for Enhancement of Competitiveness in the Indian Capital Goods Sector Phase I

    In order to address the skill gaps, infrastructure development and technology needs for the capital goods sector, Phase I of the capital goods scheme was rolled out in November 2014 which had the total outlay of Rs 995.96 crores. Phase I of the scheme fostered partnerships between academia and industry for engendering technology development with government support. The outcome of the Scheme has proved the efficacy of the strategies deployed for technology and industrial infrastructure development.

     

    • Centre of Excellence (CoE): 8 CoEs have been established wherein 30 niche indigenous technologies have been successfully developed in the fields of machine tools, additive manufacturing, textile machinery, welding robots and alloys design, earth moving machinery, and sensor technologies at national research institutes of eminence such as Indian Institute of Technology (IITs), Indian Institute of Sciences (IISc), Central Manufacturing Technology Institute (CMTI) etc.
    • Common Engineering Facility Centres (CEFC) – 15 CEFCs including four Industry 4.0 SAMARTH centres and six Web-Based Technology Innovation Platforms (TIPs) have been setup. Industry 4.0 SAMARTH centres are at Indian Institute of Sciences at Bengaluru, Centre for Industry 4.0 (C4i4) lab at Pune, Central Manufacturing Technology Institute (CMTI) at Bengaluru and Indian Institute of Technology (IIT) Delhi.
    • The six web-based open manufacturing technology innovation platforms are helping in bringing all India’s technical resources and the concerned Industry on to one platform to kick start and facilitate identification of technology problems faced by Indian Industry and crowd source solutions for the same in a systematic manner so as to facilitate start-ups and angel funding of India innovations.
    • Over 76,000 students, experts, institutes, industries and labs have already registered on these platforms so far.
    • Technology Acquisition Fund Programme (TAFP) – Following 5 technologies have been acquired from abroad under TAFP:
    1. Development & Commercialization of Titanium Casting with Ceramic Shelling Technology;
    2. Manufacturing of Heavy-Duty High Reliability Electrical Specialized Power Cables;
    3. Development of Turn Mill Centre;
    4. Development of Four Guideway CNC Lathe;
    5. Cutting Edge Robotic Laser Cladding Technology.

     

    • Integrated Machine Tools Park, Tumakuru: An exclusive industrial park for machine tool industry has been developed across 530 acres at Tumkuru, Karnataka. So far, out of 336 acres of allottable land, 145 acres of land has been allotted to the machine tool manufacturers.

     

    Under Phase- I of the Scheme for Enhancement of Competitiveness in the Indian Capital Goods Sector, 33 projects with budgetary support of Rs. 583.312 crore were sanctioned. After launching of the Capital Goods Scheme Phase II, The Phase I of the Capital Goods Scheme has been merged with Phase II of the Scheme.

     

    Scheme for Enhancement of Competitiveness in the Indian Capital Goods Sector Phase II

    Ministry of Heavy Industries notified the Phase 2 of the Scheme on January 25, 2022, with an objective to expand and enlarge the impact created by Phase I of the capital goods scheme, thereby providing greater impetus through creation of a strong and globally competitive capital goods sector. The scheme has a financial outlay of Rs. 1207 crores with budgetary support of Rs. 975 crore and industry contribution of Rs. 232 crores. Under the Phase II, a total of 33 projects with project cost of Rs 1366.94 crores (due to higher contribution by Industry) and government contribution of Rs 963.19 crore have been sanctioned by August 2024. There are six components under the Phase II and the details of the projects sanctioned so far are:

     

    • Setting up of New Advanced Centres of Excellence and augmentation of Existing Centres of Excellence: To expedite R&D by utilizing academia of repute and private industry which is involved in research and development activities. A total of 9 projects with the budget of Rs. 478.87 have been sanctioned so far.
    • Setting up of Common Engineering Facility Centres (CEFCs) and augmentation of existing CEFCs: For creating demonstration & training, consultancy, hand holding and R & D services and awareness programmes to industrial units. A total of 5 projects with the budget of Rs. 357.07 have been sanctioned so far.
    • Promotion of skilling in Capital Goods Sector: Creation of Qualification packages for skill levels 6 and above- in association with Skill Councils for skills level 6 and above. A total of 3 projects with the budget of Rs. 7.59 have been sanctioned so far.
    • Augmentation of Existing Testing and Certification Centres: To address the needs of Capital Goods Sector & Auto sector for testing of machinery in terms of various properties relating to mechanical, electrical, chemical, structural, metallurgical, electronics aspects etc. A total of 7 projects with the budget of Rs. 195.99 have been sanctioned so far.
    • Setting up of Industry Accelerators for Technology Development: Aimed at development of targeted indigenous technologies, scaled to meet the requirements of selected industry segment, which till now has been dependent on imports. Selected Academic Institute/ Industry Body will act as an Accelerator for fostering the development of such technologies. A total of 8 projects with the budget of Rs. 325.32 have been sanctioned so far.
    • Identification of Technologies through Technology Innovation Portals: Six Web-based open manufacturing technology innovation platforms have been developed under CG Scheme Phase-I. These are being supported under CG Scheme Phase-II.

     

    The details of the funds allocated and its utilization under the Scheme for Enhancement of Competitiveness in the Indian Capital Goods Sector Phase- I and II is as given in the table below:

     

     

    Recent Achievements of the Capital Goods Scheme

     

    1. Sitarc, Coimbatore has indigenously developed a 6-inch BLDC submersible pump with a motor efficiency of 88% and a pump efficiency of 78% under the Capital Goods Scheme. This initiative promotes “Aatmanirbharta” by reducing the import of such pumps by 80%. This innovation was recognized as the best product in the pumps category by United Nations Industrial Development Organization (UNIDO).
    2. CMTI has developed a high-speed rapier loom machine capable of weaving yarns upto 450 RPM. This machine was launched at ITMA 2023 in Milan, Italy.
    3. Under the SAMARTH centre at CMTI, Industrial Internet of Things (IIOT) technology has been implemented in Toyota Engine Manufacturing line controlling 64 machines for preventive maintenance.
    4. A testing facilities for battery and Battery Management System (BMS) has been established at ARAI, Pune for the first time in India under the aegis of Ministry of Heavy Industries.
    5. 6 Smart Technologies, 5 Smart Tools, 14 solutions have been developed in digital twin, virtual reality, robotics, inspection, sustainability, additive manufacturing etc. by I-4.0 India @ IISc, Bengaluru;
    6. Under Industry Accelerator at ARAI-Advanced Mobility Transformation & Innovation Foundation (AMTIF) a high-voltage motor controller developed, which enabled the industry partner Raptee Energy Private Limited to launch a high-voltage motorcycle with electric car DNA.
    7. Under Industry Accelerator at ARAI-Advanced Mobility Transformation & Innovation Foundation (AMTIF) thermally stable sodium-ion batteries developed.

     

    Bharat Heavy Electricals Limited (BHEL)

    BHEL is a major contributor towards engineering and manufacturing capacity building for the Country. The company is carrying out following initiatives with support from Ministry of Heavy industries under the Capital Goods Scheme Phase II:

    • BHEL has established a “Common Engineering Facility Centre (CEFC)” for skill development in Welding Technology at WRI Trichy along with its extension centers at Varanasi, Ranipet, Bhopal, Jhansi and Haridwar units of BHEL.

    •  BHEL is establishing a testing facility comprising both Hardware in the Loop (HIL) and Software in the Loop (SIL) functionalities in the area of Industrial, Naval and Aircraft related processes at its Corporate R&D Unit at Hyderabad with support from Ministry of Heavy Industries.

     

    Conclusion

    The ‘Make in India’ initiative has had a transformative impact on the heavy industries and engineering sector. By fostering technological advancements, increasing domestic production, enhancing competitiveness, and generating employment, the initiative has played a pivotal role in strengthening India’s industrial base. With sustained policy support and continued investment, the sector is poised for further growth in the coming years.

     

    References

    https://www.investindia.gov.in/sector/capital-goods

    https://pib.gov.in/PressReleseDetail.aspx?PRID=2098364

    https://pib.gov.in/PressReleasePage.aspx?PRID=2085938

    https://www.pib.gov.in/PressReleasePage.aspx?PRID=2042179

    https://pib.gov.in/PressReleaseIframePage.aspx?PRID=2039020

    https://www.indiabudget.gov.in/economicsurvey/doc/echapter.pdf

    https://heavyindustries.gov.in/heavy-engineering-and-machine-tool

    https://x.com/investindia/status/1302798627337723904?lang=ar-x-fm

    https://heavyindustries.gov.in/sites/default/files/2023-07/Capital-Goods-Policy-Final.pdf

    https://sansad.in/getFile/loksabhaquestions/annex/184/AU1227_CBVr5x.pdf?source=pqals

    https://sansad.in/getFile/loksabhaquestions/annex/182/AU1375_e9YzYN.pdf?source=pqals

    https://heavyindustries.gov.in/scheme-enhancement-competitiveness-indian-capital-goods-sector-phase-i

    https://heavyindustries.gov.in/scheme-enhancement-competitiveness-indian-capital-goods-sector-phase-ii

    https://heavyindustries.gov.in/sites/default/files/2025-02/heavy_annual_report_2024-25_final_27.02.2025_compressed.pdf

    Make in India and the Capital Goods Revolution

    ****

    Make in India (CG) | Explainer | 07

    Santosh Kumar | Sheetal Angral | Rishita Aggarwal

    (Release ID: 2117968) Visitor Counter : 48

    MIL OSI Asia Pacific News –

  • MIL-OSI: Delinea Partners with Microsoft to Ensure Seamless Transition and Continued Security as Microsoft Entra Permissions Management Retires

    Source: GlobeNewswire (MIL-OSI)

    SAN FRANCISCO, April 02, 2025 (GLOBE NEWSWIRE) — Delinea, a pioneering provider of solutions for securing human and machine identities through centralized authorization, has partnered with Microsoft to assist Microsoft Entra Permissions Management customers in ensuring they have continued access to advanced Cloud Infrastructure Entitlement Management (CIEM) capabilities. With Microsoft Entra Permissions Management scheduled for retirement on October 1, 2025, Delinea’s Privilege Control for Cloud Entitlements (PCCE) solution provides a strong alternative that enables enterprises to continuously discover and secure all human and machine identities across Microsoft Azure, AWS, and GCP environments.

    Delinea and Microsoft share a long-standing relationship built on a mutual commitment to delivering robust security solutions that empower enterprises to manage identities – and their access – seamlessly across multi-cloud environments. As part of this collaboration, Delinea and Microsoft are dedicated to ensuring a smooth transition for existing customers of Microsoft Entra Permissions Management. With dedicated teams in place, both companies will guide businesses through the process, helping them maximize the full capabilities of PCCE.

    “The introduction of AI has led to an explosion of human and machine identities at a time when public cloud environments are growing increasingly complex,” said Art Gilliland, CEO at Delinea. “Microsoft and Delinea share a deep, trusted relationship focused on protecting customers and securing their identities. As Microsoft’s partner for cloud entitlement security, together we are ensuring a seamless transition and continued access to cutting-edge identity security, reinforcing the trust Microsoft has placed in Delinea to support its customers.”

    Delinea’s PCCE solution enables enterprises to proactively gain control of multi-cloud environments, making it easy to identify anomalous behavior and refactor privileges. It reduces the risk of overprivileged and misconfigured identities through continuous discovery, AI-enabled analytics, and enforcing least privilege. This provides IT administrators greater visibility and deep context into cloud and identity usage to discover excess privilege and limit authorization.

    “As we are planning for the retirement of Microsoft Entra Permissions Management, Microsoft is committed to supporting every customer with a seamless transition that minimizes disruption,” said Joseph Dadzie, VP Product Management at Microsoft. “Delinea’s PCCE solution offers a scalable, innovative approach to identity security for public, multi-cloud environments, and represents an effective successor for customers of Microsoft Entra Permissions Management.”

    To learn more about Delinea’s PCCE solution, visit: https://delinea.com/microsoft-ciem

    About Delinea

    Delinea is a pioneer in securing human and machine identities through intelligent, centralized authorization, empowering organizations to seamlessly govern their interactions across the modern enterprise. Leveraging AI-powered intelligence, Delinea’s leading cloud-native Identity Security Platform applies context throughout the entire identity lifecycle – across cloud and traditional infrastructure, data, SaaS applications, and AI. It is the only platform that enables you to discover all identities – including workforce, IT administrator, developers, and machines – assign appropriate access levels, detect irregularities, and respond to threats in real-time. With deployment in weeks, not months, 90% fewer resources to manage than the nearest competitor, and a guaranteed 99.99% uptime, Delinea delivers robust security and operational efficiency without compromise. Learn more about Delinea on delinea.com, LinkedIn, X, and YouTube.  

    The MIL Network –

  • MIL-OSI United Kingdom: Fly tipping blitz campaign and community lounge partnership shortlisted for national awards

    Source: City of Stoke-on-Trent

    Published: Tuesday, 1st April 2025

    An innovative community partnership that has helped more than 4,000 people access vital support and a council service leading a blitz on fly-tipping are up for awards that recognise local government.

    Environmental Services is nominated for ‘Best Council Services Team’ at the MJ Achievement Awards 2025, while the Communities Together scheme is up for the ‘Community Engagement Award’.

    The first relates to the IDIOT (Illegal Dumping in Our Towns) campaign, which was launched in 2023 after fly tipping emerged as a major concern during that year’s local elections. It pledged rapid responses to clearing dumped waste, tougher enforcement and educating the community.

    The initial aim was to clear 1,000 fly tipping incidents in the first 100 days and this was achieved in half the time. This initial crackdown resulted in 2,395 clearances of illegal waste, as well as 523 fixed penalty notices.

    By the end of 2024, 7,661 reported fly tipping incidents were cleared and the average time when responding to these fell to just 3.3 days on average (previously 13.1 days).

    This was an 84 per cent increase in reports on the previous 16 months – with the much-improved visual appearance of the city and the upsurge of civil pride amounts to a resounding success.

    In addition, Communities Together has evolved from the community and city council’s response to the Covid-19 pandemic, becoming a local partnership programme to set up locations where people can easily access help, advice and support.

    There are now 18 community lounges across Stoke-on-Trent, with each one tailored to the unique needs and characteristics of their location – effectively helping reduce health inequalities.

    Through this more focused and preventative approach, Communities Together has helped reduce the stigma around seeking help, promoted independence and reduced pressure on other services.

    Since April 2024, the community lounges have helped 4,019 residents in a wide range of areas:

    • 1,273 people received emergency food provision
    • 783 people had help with financial matters
    • 737 people has help with housing
    • 196 people received mental health support
    • 159 people received help with homelessness

    Councillor Jane Ashworth, leader of Stoke-on-Trent City Council, said: “Having two projects receiving national recognition at the MJ Awards is an amazing achievement and a reflection of the hard work so many of the city council and our partners have put in to accomplish this.

    “By promoting community cohesion, we have been able to help and support residents in a variety of ways, whilst also helping communities look and feel healthier through the crackdown on fly tipping.

    “Congratulations to all involved on their hard work and dedication and wishing you the best of luck at the upcoming MJ Awards ceremony.”

    The winners of the MJ Awards will be announced at a ceremony at Park Plaza Westminster Bridge on Friday 20th June 2025.

    MIL OSI United Kingdom –

  • MIL-OSI: LLumin CMMS+ Achieves “Sage Intacct Recommended” Status for Delivering Seamless Maintenance and Financial Integration

    Source: GlobeNewswire (MIL-OSI)

    SPRINGFIELD, Mass., March 31, 2025 (GLOBE NEWSWIRE) — LLumin, the leading CMMS (computerized maintenance management system) provider, announces the integration of its best-of-breed asset maintenance software with Sage Intacct, the powerful cloud financial management system and trusted software provider for small and mid-sized businesses (SMBs) in industrial manufacturing and automation. Having joined the Sage ERP Partner Ecosystem, LLumin’s CMMS+ integration with Sage Intacct has earned “Sage Recommended” status and secured a new member listing on the Sage Intacct Marketplace.

    “Achieving a single source of truth is crucial for any organization, especially manufacturers striving for peak operational efficiency. The integration of LLumin CMMS+ with Sage Intacct, including our newest AI-powered features, provides manufacturers with a unified platform that eliminates data silos and enables informed, data-driven decision-making, resulting in improved maintenance and asset management,” stated Dan Miller, EVP Financials and ERP Division at Sage.

    This robust integration allows for a seamless flow of information between maintenance and finance, including intelligent time tracking and financial oversight. The software’s versatility makes it ideal for managing a wider range of assets, including facilities, fleets, and infrastructure.

    “This integration isn’t just about fixing problems; it’s about preventing them. LLumin CMMS+ and Sage Intacct together enable manufacturers to proactively manage assets, minimize disruptions, and gain a decisive operations competitive edge, all while optimizing their financial performance,” said Ed Garibian, LLumin CEO.said Ed Garibian, LLumin CEO.

    The powerful rule-based workflows and automated work order generation in CMMS+, provides manufacturers the right approach to optimize maintenance operations, reduce downtime, and extend asset life. The CMMS + integration with Sage Intacct delivers a seamless connection between maintenance operations and financial records, providing such significant benefits to customers as:

    • Streamlined Spare Parts Management: Leverage LLumin’s best-in-class spare parts inventory and procurement capabilities to ensure accurate stock levels and timely reordering.
    • Elimination of Duplicate Data Entry: Automatically sync invoices for spare parts between LLumin CMMS+ and Sage Intacct, reducing manual input and minimizing errors.
    • Improved Financial Accuracy: Ensure consistency between maintenance operations and financial records by seamlessly integrating procurement data with Sage Intacct’s accounting system.
    • Enhanced Efficiency: Save time and resources by automating workflows between maintenance and finance teams, improving overall operational productivity.

    For more information about LLumin CMMS+ and its integration with Sage Intacct, please visit LLumin.com.

    About Sage

    Sage exists to knock down barriers so everyone can thrive, starting with the millions of Small and Mid-Sized Businesses served by us, our partners and accountants. Customers trust our finance, HR and payroll software to make work and money flow. By digitizing business processes and relationships with customers, suppliers, employees, banks and governments, our digital network connects SMBs, removing friction and delivering insights. Knocking down barriers also means we use our time, technology and experience to tackle digital inequality, economic inequality and the climate crisis. For more information, visit Sage.

    About LLumin:

    The team at LLumin possesses decades of experience in the CMMS software industry, managing fleet, facilities, and industrial machinery for all industries. Having developed CMMS+ as a IOT and Industry 4.0 first Asset Performance and Maintenance Management solution suite, the software delivers ROI by improving Asset Uptime and OEE levels, lowering MTTR metrics, and extending the life of asset lifecycles. For more information, visit LLumin.com.

    Media Contact:

    Valerie Harding,
    Ripple Effect Communications
    Email: valerie@RippleEffectPR.com
    Tel: 617-536-8887

    A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/09466f8f-7b16-4899-8101-07868790dd6c

    The MIL Network –

  • MIL-OSI: Form 8.3 – [ADVANCED MEDICAL SOLUTIONS GROUP PLC – 28 03 2025] – (CGWL)

    Source: GlobeNewswire (MIL-OSI)

    FORM 8.3

    PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY
    A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE
    Rule 8.3 of the Takeover Code (the “Code”)

    1.        KEY INFORMATION

    (a)   Full name of discloser: CANACCORD GENUITY WEALTH LIMITED (for Discretionary clients)
    (b)   Owner or controller of interests and short positions disclosed, if different from 1(a):
            The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.    		 N/A
    (c)   Name of offeror/offeree in relation to whose relevant securities this form relates:
            Use a separate form for each offeror/offeree    		 ADVANCED MEDICAL SOLUTIONS GROUP PLC
    (d)   If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree: N/A
    (e)   Date position held/dealing undertaken:
            For an opening position disclosure, state the latest practicable date prior to the disclosure    		 28 MARCH 2025
    (f)   In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?
            If it is a cash offer or possible cash offer, state “N/A”    		 N/A

    2.        POSITIONS OF THE PERSON MAKING THE DISCLOSURE

    If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

    (a)      Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

    Class of relevant security: 5p ORDINARY
      Interests Short positions
    Number % Number %
    (1)   Relevant securities owned and/or controlled: 11,918,972 5.4677    
    (2)   Cash-settled derivatives:        
    (3)   Stock-settled derivatives (including options) and agreements to purchase/sell:        
    TOTAL: 11,918,972 5.4677    

    On 28thMarch there was a transfer out of our discretionary management of 3,250 shares

    All interests and all short positions should be disclosed.

    Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

    (b)      Rights to subscribe for new securities (including directors’ and other employee options)

    Class of relevant security in relation to which subscription right exists:  
    Details, including nature of the rights concerned and relevant percentages:  

    3.        DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

    Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

    The currency of all prices and other monetary amounts should be stated.

    (a)        Purchases and sales

    Class of relevant security Purchase/sale Number of securities Price per unit
    5p ORDINARY SALE 600 228.5p
    5p ORDINARY SALE 666 229p
    5p ORDINARY SALE 5,000 229.18p
    5p ORDINARY SALE 4,500 229.5p
    5p ORDINARY SALE 1,000 230p
    5p ORDINARY SALE 2,239 231p
    5p ORDINARY SALE 995 231.5p
    5p ORDINARY SALE 1,520 236.65p
    5p ORDINARY SALE 7,435 238.18p
    5p ORDINARY PURCHASE 1,520 237.1p

    (b)        Cash-settled derivative transactions

    Class of relevant security Product description
    e.g. CFD    		 Nature of dealing
    e.g. opening/closing a long/short position, increasing/reducing a long/short position    		 Number of reference securities Price per unit
    NONE        

    (c)        Stock-settled derivative transactions (including options)

    (i)        Writing, selling, purchasing or varying

    Class of relevant security Product description e.g. call option Writing, purchasing, selling, varying etc. Number of securities to which option relates Exercise price per unit Type
    e.g. American, European etc.    		 Expiry date Option money paid/ received per unit
    NONE              

    (ii)        Exercise

    Class of relevant security Product description
    e.g. call option    		 Exercising/ exercised against Number of securities Exercise price per unit

    (d)        Other dealings (including subscribing for new securities)

    Class of relevant security Nature of dealing
    e.g. subscription, conversion    		 Details Price per unit (if applicable)
    NONE      

    4.        OTHER INFORMATION

    (a)        Indemnity and other dealing arrangements

    Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:
    Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state “none”

    NONE

    (b)        Agreements, arrangements or understandings relating to options or derivatives

    Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to:
    (i)   the voting rights of any relevant securities under any option; or
    (ii)   the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:
    If there are no such agreements, arrangements or understandings, state “none”

    NONE

    (c)        Attachments

    Is a Supplemental Form 8 (Open Positions) attached? NO
    Date of disclosure: 31 MARCH 2025
    Contact name: MARK ELLIOTT
    Telephone number: 01253 376539

    Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

    The Panel’s Market Surveillance Unit is available for consultation in relation to the Code’s disclosure requirements on +44 (0)20 7638 0129.

    The Code can be viewed on the Panel’s website at www.thetakeoverpanel.org.uk.

    The MIL Network –

  • MIL-OSI: Form 8.3 – [ADVANCED MEDICAL SOLUTIONS GROUP PLC – 27 03 2025] – (CGWL)

    Source: GlobeNewswire (MIL-OSI)

    FORM 8.3

    PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY
    A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE
    Rule 8.3 of the Takeover Code (the “Code”)

    1.        KEY INFORMATION

    (a)   Full name of discloser: CANACCORD GENUITY WEALTH LIMITED (for Discretionary clients)
    (b)   Owner or controller of interests and short positions disclosed, if different from 1(a):
            The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.    		 N/A
    (c)   Name of offeror/offeree in relation to whose relevant securities this form relates:
            Use a separate form for each offeror/offeree    		 ADVANCED MEDICAL SOLUTIONS GROUP PLC
    (d)   If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree: N/A
    (e)   Date position held/dealing undertaken:
            For an opening position disclosure, state the latest practicable date prior to the disclosure    		 27 MARCH 2025
    (f)   In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?
            If it is a cash offer or possible cash offer, state “N/A”    		 N/A

    2.        POSITIONS OF THE PERSON MAKING THE DISCLOSURE

    If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

    (a)      Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

    Class of relevant security: 5p ORDINARY
      Interests Short positions
    Number % Number %
    (1)   Relevant securities owned and/or controlled: 11,944,657 5.4795    
    (2)   Cash-settled derivatives:        
    (3)   Stock-settled derivatives (including options) and agreements to purchase/sell:        
    TOTAL: 11,944,657 5.4795    

    On 27thMarch there was a transfer into our discretionary management of 1,096 shares

    All interests and all short positions should be disclosed.

    Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

    (b)      Rights to subscribe for new securities (including directors’ and other employee options)

    Class of relevant security in relation to which subscription right exists:  
    Details, including nature of the rights concerned and relevant percentages:  

    3.        DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

    Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

    The currency of all prices and other monetary amounts should be stated.

    (a)        Purchases and sales

    Class of relevant security Purchase/sale Number of securities Price per unit
    5p ORDINARY SALE 12,500 198.66p
    5p ORDINARY SALE 945 231.361p
    5p ORDINARY PURCHASE 1,500 198.9p
    5p ORDINARY PURCHASE 4,000 233.2475p
    5p ORDINARY PURCHASE 2,000 234.9p
    5p ORDINARY PURCHASE 12,500 235p
    5p ORDINARY PURCHASE 2,500 235.55p

    (b)        Cash-settled derivative transactions

    Class of relevant security Product description
    e.g. CFD    		 Nature of dealing
    e.g. opening/closing a long/short position, increasing/reducing a long/short position    		 Number of reference securities Price per unit
    NONE        

    (c)        Stock-settled derivative transactions (including options)

    (i)        Writing, selling, purchasing or varying

    Class of relevant security Product description e.g. call option Writing, purchasing, selling, varying etc. Number of securities to which option relates Exercise price per unit Type
    e.g. American, European etc.    		 Expiry date Option money paid/ received per unit
    NONE              

    (ii)        Exercise

    Class of relevant security Product description
    e.g. call option    		 Exercising/ exercised against Number of securities Exercise price per unit

    (d)        Other dealings (including subscribing for new securities)

    Class of relevant security Nature of dealing
    e.g. subscription, conversion    		 Details Price per unit (if applicable)
    NONE      

    4.        OTHER INFORMATION

    (a)        Indemnity and other dealing arrangements

    Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:
    Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state “none”

    NONE

    (b)        Agreements, arrangements or understandings relating to options or derivatives

    Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to:
    (i)   the voting rights of any relevant securities under any option; or
    (ii)   the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:
    If there are no such agreements, arrangements or understandings, state “none”

    NONE

    (c)        Attachments

    Is a Supplemental Form 8 (Open Positions) attached? NO
    Date of disclosure: 28 MARCH 2025
    Contact name: MARK ELLIOTT
    Telephone number: 01253 376539

    Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

    The Panel’s Market Surveillance Unit is available for consultation in relation to the Code’s disclosure requirements on +44 (0)20 7638 0129.

    The Code can be viewed on the Panel’s website at www.thetakeoverpanel.org.uk.

    The MIL Network –

  • MIL-OSI: Form 8.3 – [ADVANCED MEDICAL SOLUTIONS GROUP PLC – Opening Disclosure – 27 03 2025] – (CGAML)

    Source: GlobeNewswire (MIL-OSI)

    FORM 8.3

    PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY
    A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE
    Rule 8.3 of the Takeover Code (the “Code”)

    1.        KEY INFORMATION

    (a)   Full name of discloser: CANACCORD GENUITY ASSET MANAGEMENT LIMITED (for Discretionary clients)
    (b)   Owner or controller of interests and short positions disclosed, if different from 1(a):
            The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.    		 N/A
    (c)   Name of offeror/offeree in relation to whose relevant securities this form relates:
            Use a separate form for each offeror/offeree    		 ADVANCED MEDICAL SOLUTIONS GROUP PLC
    (d)   If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree: N/A
    (e)   Date position held/dealing undertaken:
            For an opening position disclosure, state the latest practicable date prior to the disclosure    		 27 MARCH 2025
    (f)   In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?
            If it is a cash offer or possible cash offer, state “N/A”    		 N/A

    2.        POSITIONS OF THE PERSON MAKING THE DISCLOSURE

    If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

    (a)      Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

    Class of relevant security: 5p ORDINARY
      Interests Short positions
    Number % Number %
    (1)   Relevant securities owned and/or controlled: 4,650,000 2.1331    
    (2)   Cash-settled derivatives:        
    (3)   Stock-settled derivatives (including options) and agreements to purchase/sell:        
    TOTAL: 4,650,000 2.1331    

    All interests and all short positions should be disclosed.

    Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

    (b)      Rights to subscribe for new securities (including directors’ and other employee options)

    Class of relevant security in relation to which subscription right exists:  
    Details, including nature of the rights concerned and relevant percentages:  

    3.        DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

    Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

    The currency of all prices and other monetary amounts should be stated.

    (a)        Purchases and sales

    Class of relevant security Purchase/sale Number of securities Price per unit
    None      

    (b)        Cash-settled derivative transactions

    Class of relevant security Product description
    e.g. CFD    		 Nature of dealing
    e.g. opening/closing a long/short position, increasing/reducing a long/short position    		 Number of reference securities Price per unit
    NONE        

    (c)        Stock-settled derivative transactions (including options)

    (i)        Writing, selling, purchasing or varying

    Class of relevant security Product description e.g. call option Writing, purchasing, selling, varying etc. Number of securities to which option relates Exercise price per unit Type
    e.g. American, European etc.    		 Expiry date Option money paid/ received per unit
    NONE              

    (ii)        Exercise

    Class of relevant security Product description
    e.g. call option    		 Exercising/ exercised against Number of securities Exercise price per unit

    (d)        Other dealings (including subscribing for new securities)

    Class of relevant security Nature of dealing
    e.g. subscription, conversion    		 Details Price per unit (if applicable)
    NONE      

    4.        OTHER INFORMATION

    (a)        Indemnity and other dealing arrangements

    Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:
    Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state “none”

    NONE

    (b)        Agreements, arrangements or understandings relating to options or derivatives

    Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to:
    (i)   the voting rights of any relevant securities under any option; or
    (ii)   the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:
    If there are no such agreements, arrangements or understandings, state “none”

    NONE

    (c)        Attachments

    Is a Supplemental Form 8 (Open Positions) attached? NO
    Date of disclosure: 28 MARCH 2025
    Contact name: MARK ELLIOTT
    Telephone number: 01253 376539

    Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

    The Panel’s Market Surveillance Unit is available for consultation in relation to the Code’s disclosure requirements on +44 (0)20 7638 0129.

    The Code can be viewed on the Panel’s website at www.thetakeoverpanel.org.uk.

    The MIL Network –

  • MIL-OSI USA: REPS. LAUREN BOEBERT AND TOM TIFFANY’S GRAY WOLF BILL RECEIVES KEY HEARING IN HOUSE SUBCOMMITTEE

    Source: United States House of Representatives – Representative Lauren Boebert (Colorado, 3)

    WASHINGTON D.C.– The Pet and Livestock Protection Act introduced by Congresswoman Lauren Boebert (CO-04) and Congressman Tom Tiffany (WI-07) today received a key hearing in the House Natural Resources Subcommittee on Water, Wildlife, and Fisheries.

    The bill delists the gray wolf from the Endangered Species List, prioritizes the safety and success of America’s agriculture community, removes the ability of progressive, activist judges to get in the way of science and allows states to set their own rules and regulations for managing their gray wolf population. 

    “The science is very clear on this issue: gray wolves should no longer be on the Endangered Species List,”said Congresswoman Boebert. “We can no longer put the livestock of ranchers and farmers in harm’s way by protecting a species that has fully recovered and does not recognize state boundaries. Administrations on both sides of the aisle have agreed this change needs to happen and I look forward to implementing this legislation into law so activist, progressive judges will no longer be able to put their ideology over the rights of ranchers and farmers across Colorado and America.”

    “We’ve all witnessed the slaughter of pets, livestock, and deer herds across rural America as a result of an unmanaged gray wolf population. The science is clear; the gray wolf has recovered. Rep. Boebert and I introduced the Pet and Livestock Protection Act to delist the gray wolf, restore state management, and protect the livelihoods of farmers and pet owners. Wolf management belongs in the hands of states, not distant D.C. bureaucrats,” said Congressman Tiffany.

    “The Pet and Livestock Protection Act would formalize what the Department of the Interior has repeatedly stated under multiple presidential administrations—that gray wolves are recovered, have exceeded the established delisting criteria, and that states should regain management authority as originally intended under the ESA,” said Dr. Nathan Roberts, Professor of Conservation and Wildlife Management at College of the Ozarks and testifying witness at today’s hearing. “The bills discussed today will promote responsible wildlife management and stewardship, helping to restore balance and ensure effective conservation practices.”

    Congresswoman Boebert’s entire opening statement from today’s hearing can be viewed HERE.

    Additional Reading:

    9News: Wolf from Great Lakes dies in Elbert County, Colorado

    USA Today: Colorado Gray Wolf killed after attacking 5 sheep in Wyoming

    The Gazette: Wolves from Canada Arrive in Colorado, Destination Unknown

    Colorado Sun: Ranchers hit Colorado with $580,000 in wolf depredation claims after gray wolf attacks on livestock

    Background:

    The Pet and Livestock Protection Act requires the Secretary of the Interior to reissue the 2020 Department of the Interior final rule that delisted gray wolves in the lower 48 United States. It also ensures this rule cannot be overturned through judicial review, preventing activist judges, like the California judge who vacated the rule in 2022, from relisting the gray wolf by judicial fiat.

    In 2020, the Department of the Interior and the U.S. Fish and Wildlife Service under President Trump delisted the gray wolf in the lower 48 United States through a process that included the best science and data available. At over 6,000 wolves at the time of delisting, the gray wolf has been the latest Endangered Species Act (ESA) success story with significant population recoveries in the Rocky Mountains and western Great Lakes regions.

    Despite clear evidence of recovery, a California judge overturned the rule in 2022, relisting the gray wolf under the ESA. In Colorado, foreign gray wolves have been imported in from Canada despite strong pushback from local stakeholders and confusion about how to fund wolf depredation claims.

    31 Members of Congress cosponsored the Pet and Livestock Protection Act, including: Reps. Nick Begich (AK-At-Large), Jack Bergman (MI-01), Andy Biggs (AZ-05), Cliff Bentz (OR-02), Jeff Crank (CO-05), Eli Crane (AZ-02), Troy Downing (MT-02), Tom Emmer (MN-06), Gabe Evans (CO-08), Scott Fitzgerald (WI-05), Brad Finstad (MN-01), Michelle Fischbach (MN-07), Russ Fulcher (ID-01), Paul Gosar (AZ-09), Glenn Grothman (WI-06), Harriet Hagemann (WY-At-Large), Andy Harris (MD-01), Jeff Hurd (CO-03), Richard Hudson (NC-09), Mike Kennedy (UT-03), Doug LaMalfa (CA-01), Max Miller (OH-07), John Moolenaar (MI-02), Dan Newhouse (WA-04), Troy Nehls (TX-22), Andy Ogles (TN-05), Scott Perry (PA-10), Bryan Steil (WI-01), Pete Stauber (MN-08), Derrick Van Orden (WI-03), and Tony Wied (WI-08).

    Stakeholders that support the Pet and Livestock Protection Act include: American Farm Bureau Federation, National Cattlemen’s Beef Association (NCBA), Public Lands Council (PLC), National Rifle Association (NRA), Safari Club International (SCI), Hunter Nation, International Order of T. Roosevelt (IOTR), Congressional Sportsmen’s Foundation, Mule Deer Foundation, Blacktail Deer Foundation, Colorado Farm Bureau, Colorado Conservation Alliance, Colorado Wool Growers, New Mexico Cattle Growers, Minnesota Lamb & Wool Producers Association, Coalition of Arizona/New Mexico Counties, Rocky Mountain Elk Foundation, Wisconsin Farm Bureau Federation, Wisconsin Cattlemen’s Association, Nebraska Cattlemen, and Wisconsin Bear Hunters Association.

    MIL OSI USA News –

  • MIL-OSI: ARB IOT Group Limited Unveils Cutting-Edge Smart AI Robot to Revolutionize Fertilization in Agriculture

    Source: GlobeNewswire (MIL-OSI)

    Kuala Lumpur, Malaysia, March 27, 2025 (GLOBE NEWSWIRE) — ARB IOT Group Limited (“ARB IOT” or the “Company”) (NASDAQ: ARBB) has unveiled its AI-powered fertilizer system that seamlessly integrates the intelligent multi-functional agricultural robot (“Smart AI Robot”). This innovation is set to revolutionize modern farming by optimising fertilisation processes, enhancing crop yield, and promoting sustainable farming. This advanced AI-powered robot represents a significant leap forward in precision agriculture.

    The Smart AI Robot features unmanned field operations, modular design, all-terrain capability, centimetre-level positioning, ultra-long endurance, quick-replaceable battery, and precise operation, among others. It can be widely used in various types of plants such as palm oil, durian, lychee, mango, citrus, and orchards to realize unmanned spraying, mowing, fertilizing and delivery. The Company’s AI-powered fertilizer system will contribute to the materialization of a new mode of environmentally friendly agriculture production, through a series of new energy unmanned robotics and a big data platform that carry out intelligent and standardized management of various types of agricultural plants with fully automated fertilization, pesticide application, diagnostic scanning of plant and fruit conditions, and soil NPK (nitrogen, phosphorus, potassium) measurement.

    It is estimated that by 2027, approximately 35% of Malaysia’s oil palm land will be overaged. Currently, only approximately 17% of such land has trees in the optimal four to eight-year range where motorised cutters could be effective—though their performance remains inconsistent. In Sabah and Sarawak, which account for approximately 55% of Malaysia’s oil palm areas, the terrain is dominated by steep hills and vast peatlands.

    The Company’s AI-powered fertilizer system utilizes cutting-edge machine learning algorithms and real-time soil data analysis to determine the precise amount of fertilizer needed for each section of farmland. When paired with the Smart AI Robot, the system is able to automate fertilizer application, minimize waste, maximize crop yield, and reduce environmental impact.

    “Traditional farming methods often rely on manual labor and generic fertilizer application, leading to inefficiencies and excessive resource consumption. By integrating AI and automation, our Smart AI Robot empowers farmers with more efficient and sustainable farming practices. This technology is a major step towards addressing global food security and environmental challenges” said Dato’ Sri Liew Kok Leong, CEO of ARB IOT. “With our AI-driven solution, farmers can now achieve precision farming at an unprecedented scale, ensuring optimal nutrient distribution tailored to specific crop and soil conditions.”

    Key benefits of the integrated Smart AI Robot include:

    • Precision Application: AI-driven data analytics ensure targeted fertilizer distribution, reducing overuse and underuse.
    • Automation and Efficiency: The autonomous agricultural robot reduces the need for manual labor, operating seamlessly across vast farmlands.
    • Sustainability: By minimizing fertilizer runoff and optimizing nutrient absorption, the system supports eco-friendly farming practices.
    • Cost Reduction: The conversion of solid fertilizers to liquid form leads to cost savings by reducing waste and improving absorption efficiency.
    • Real-time Monitoring: The AI system continuously collects and analyzes soil health and crop growth data, allowing for timely adjustments.

    The convergence of IoT technology with our smart farming system enables real-time monitoring through strategically placed sensors across plantations. These sensors capture data on soil moisture, temperature, humidity and other key environmental factors, providing farmers with instant insights via a central digital hub. This empowers them to make data-driven decisions, respond proactively to environmental changes and optimize farm productivity.

    With a focus on AI-driven advancements, we aim to drive progress in precision agriculture worldwide.

    About ARB IOT Group Limited

    ARB IOT Group Limited is a provider of complete solutions to clients for the integration of Internet of Things (IoT) systems and devices from designing to project deployment. We offer a wide range of IoT systems as well as provide customers a substantial range of services such as system integration and system support service. We deliver holistic solutions with full turnkey deployment from designing, installation, testing, pre-commissioning, and commissioning of various IoT systems and devices as well as integration of automated systems, including installation of wire and wireless and mechatronic works.

    Safe Harbor Statement

    This press release contains “forward-looking statements” that involve substantial risks and uncertainties. All statements other than statements of historical facts contained in this press release, such as statements regarding our estimated future results of operations and financial position, our strategy and plans, and our objectives or goals, are forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended and Section 21E of the Securities Exchange Act of 1934, as amended. We have attempted to identify forward-looking statements by terminology including “anticipates,” “believes,” “can,” “continue,” “could,” “estimates,” “expects,” “intends,” “may,” “plans,” “potential,” “predicts,” “should,” or “will” or the negative of these terms or other comparable terminology. Our actual results may differ materially or perhaps significantly from those discussed herein, or implied by, these forward-looking statements. There are a significant number of factors that could cause actual results to differ materially from statements made in this press release, including, but not limited to, those that we discussed or referred to in the Company’s disclosure documents filed with the U.S. Securities and Exchange Commission (the “SEC”) available on the SEC’s website at www.sec.gov, including the Company’s Annual Report on Form 20-F as well as in our other reports filed or furnished from time to time with the SEC. The forward-looking statements included in this press release are made as of the date of this press release and the Company undertakes no obligation to publicly update or revise any forward looking statements, other than as required by applicable law.

    For further information, please contact:
    ARB IOT Group Limited
    Investor Relations Department
    Email: contact@arbiotgroup.com

    The MIL Network –

  • MIL-OSI Europe: Denmark: IO Biotech secures up to €57.5 million EIB venture debt to advance cancer vaccine research and development.

    Source: European Investment Bank

    EIB

    • Further support for Denmark’s med-tech sector as IO Biotech boost cancer vaccine research with EIB venture debt financing.
    • IO Biotech will use the financing for its innovative immunotherapeutic cancer vaccine to treat melanoma.
    • The EIB’s financing is backed under the European Commission’s InvestEU initiative.

    Danish med-tech company IO Biotech has signed a €57.5 million venture debt deal with the European Investment Bank. The debt facility includes three committed tranches totalling up to €37.5 million, which will become available if the company satisfies certain conditions, and one uncommitted accordion tranche of €20 million. The clinical-stage biopharmaceutical company is developing novel, immune-modulating cancer vaccine therapies based on an innovative proprietary technology platform. The company will mainly use the financing for the development and market launch of IO102-IO103, an immunotherapeutic cancer vaccine to treat melanoma, with a view to employing the vaccine more broadly against other types of cancer. The EIB financing is supported by the European Commission’s InvestEU programme.

    The EIB financing will, on the one hand, support the finalisation of the clinical development as well as the regulatory approval and market launch of the lead candidate. On the other hand, the financing will also support the development of new product candidates generated through the Company’s platform. The funding is expected to enable IO Biotech to grow from a pure R&D company into a fully-fledged pharma company with products forming the backbone of combination therapy for people with cancer.

    “Innovative European companies not only need capital but also investors willing to take risks, allowing them to scale up and reach commercialization before non-EU investors step in.” said EIB Vice-President Ioannis Tsakiris. “IO Biotech’s groundbreaking technology has the potential to significantly impact healthcare, particularly in oncology. Bringing new pharmaceutical products to market requires substantial investment, especially in the final stages of development. With the support of the European Commission’s InvestEU programme, the EIB is bridging this funding gap, ensuring that cutting-edge European technology can grow, thrive, and benefit patients across the EU.”

    Amy Sullivan, Chief Financial Officer of IO Biotech, commented, “We appreciate the support we have received from the EIB with this transaction. This debt facility will help fund the continued development and pre-commercialization of our therapeutic cancer vaccine candidates generated from our T-Win® platform. This funding comes at a critical time for our company as we approach the results from the phase 3 pivotal study of our lead investigational therapeutic cancer vaccine, IO102-IO103, in the third quarter of 2025.”

    Background information

    The European Investment Bank is the long-term lending institution of the European Union, owned by its Member States. It finances investments that contribute to EU policy objectives. EIB projects bolster competitiveness, drive innovation, promote sustainable development, enhance social and territorial cohesion, contribute to peace and security, and support a just and swift transition to climate neutrality. The Group’s AAA rating allows it to borrow at favourable conditions on the global markets, benefiting its clients within the European Union and beyond. The Group has the highest ESG standards and a tier one capital ratio of 32%.

    The InvestEU programme provides the European Union with crucial long-term funding by leveraging substantial private and public funds in support of a sustainable economy. It helps generate additional investments in line with EU policy priorities, such as the European Green Deal, the digital transition and support for small and medium-sized enterprises. InvestEU brings all EU financial instruments together under one roof, making funding for investment projects in Europe simpler, more efficient, and more flexible. The programme consists of three components: the InvestEU Fund, the InvestEU Advisory Hub, and the InvestEU Portal. The InvestEU Fund is implemented through financial partners who invest in projects using the EU budget guarantee of €26.2 billion. This guarantee increases their risk-bearing capacity, thus mobilising at least €372 billion in additional investment.

    IO Biotech is a clinical-stage biopharmaceutical company developing novel, immune-modulating therapeutic cancer vaccines based on its T-win® platform. The T-win platform is based on a novel approach to cancer vaccines designed to activate T cells to target the immunosuppressive cells in the tumor microenvironment. IO Biotech is advancing its lead cancer vaccine candidate, IO102-IO103, in clinical trials, and additional pipeline candidates through preclinical development. IO Biotech is headquartered in Copenhagen, Denmark and has US headquarters in New York, New York.High-quality, up-to-date photos of our headquarters for media use are available here.

    IO BIOTECH (IEU LS)
    IO BIOTECH (IEU LS)
    ©EIB
    Download original
    IO BIOTECH (IEU LS)
    IO BIOTECH (IEU LS)
    ©EIB
    Download original
    European Commission logo EN
    European Commission logo
    ©European Commission
    Download original

    MIL OSI Europe News –

  • MIL-OSI Video: National Medal of Honor Day 2025 at The White House

    Source: United States of America – The White House (video statements)

    “On National Medal of Honor Day, it was my Great Honor to recognize our Nation’s BRAVEST HEROES and incredible PATRIOTS who have been awarded the military’s highest honor. Thank you!” –President Donald J. Trump

    https://www.youtube.com/watch?v=NR1Pqn-ka8k

    MIL OSI Video –